Amedeo Smart

Free Medical Literature Service

 

Amedeo

Rheumatoid Arthritis
  Free Subscription

Articles published in
Clin Rheumatol
    October 2026
  1. CAI W, Zheng X
    Association between patterns of circulating vitamin co-exposure and the prognosis of rheumatoid arthritis.
    Clin Rheumatol. 2026 Oct 9. doi: 10.1007/s10067-026-08459.
    >> Share

  2. MAJJAD A, Assad HE, Marbouh ELKE, Belhadj W, et al
    Sex differences in rheumatoid arthritis: results of a cross-sectional study.
    Clin Rheumatol. 2026 Oct 6. doi: 10.1007/s10067-026-08458.
    >> Share

  3. ERTURK R, Oncar LS, Cengiz ECE, Celikdelen SO, et al
    Visit adherence and clinical, inflammatory, and patient-reported outcomes in rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2026 Oct 6. doi: 10.1007/s10067-026-08465.
    >> Share

  4. PAPAMICHAIL GV, Chrysanthopoulou A, Georgiadis NA, Kapsali CA, et al
    Neutrophil extracellular trap suppression in rheumatoid arthritis patients treated with biologic therapy: a prospective observational study.
    Clin Rheumatol. 2026 Oct 3. doi: 10.1007/s10067-026-08454.
    >> Share

  5. FEDKOV D, Koliadenko D, Petelytska L, Peine C, et al
    Digital physical-activity engagement and 12-week patient-reported outcomes in inflammatory arthritis: a retrospective real-world cohort study.
    Clin Rheumatol. 2026;45:6011-6022.
    >> Share

  6. LI Y, Xiao G, Dou R, Liu H, et al
    Anti-centromere antibody positivity: a spectrum of clinical diagnoses and immunological patterns in a large patient cohort.
    Clin Rheumatol. 2026;45:5979-5987.
    >> Share

  7. ZHOU Z, Zheng K, Zheng S, Chen C, et al
    Diagnostic performance of lung ultrasound B-lines and serum KL-6 in detecting Sjogren's disease-related interstitial lung diseases.
    Clin Rheumatol. 2026;45:6189-6198.
    >> Share

    September 2026
  8. TOMITA D, Nozaki Y, Fukuda R, Morimoto Y, et al
    Renal function-adjusted initial JAK inhibitor dosing and outcomes in rheumatoid arthritis: from the ANSWER cohort study.
    Clin Rheumatol. 2026 Sep 29. doi: 10.1007/s10067-026-08448.
    >> Share

  9. HARAGUCHI A, Kuga T, Kaneda S, Kamo K, et al
    Foot and ankle pain in rheumatoid arthritis: the symptom is the signal, the underlying pathology the treatment target.
    Clin Rheumatol. 2026 Sep 28. doi: 10.1007/s10067-026-08409.
    >> Share

  10. KANG XM, Hu PC, Long ZY, Chen Y, et al
    Comparison and validation of systemic immune-inflammation index, C-reactive protein/albumin ratio, and C-reactive protein-albumin-lymphocyte index for assessing disease activity in rheumatoid arthritis.
    Clin Rheumatol. 2026 Sep 25. doi: 10.1007/s10067-026-08424.
    >> Share

  11. JAHAN S, Rahim A, Ayub S, Salim B, et al
    Impaired telomere maintenance in rheumatoid arthritis: a case-control study of telomerase reverse transcriptase and telomeric repeat-binding factors in disease susceptibility and functional impairment.
    Clin Rheumatol. 2026 Sep 22. doi: 10.1007/s10067-026-08447.
    >> Share

  12. YANG G, Zhao P, Jia J
    Persistent foot and ankle pain in rheumatoid arthritis remission: what is the treatment target?
    Clin Rheumatol. 2026 Sep 20. doi: 10.1007/s10067-026-08434.
    >> Share

  13. AZZAM AI, Khalifa AM
    Pain-inflammation discordance in rheumatoid arthritis: fibromyalgia, psychological, and functional correlates of a continuous metric.
    Clin Rheumatol. 2026 Sep 17. doi: 10.1007/s10067-026-08411.
    >> Share

  14. CUENCA-ZALDIVAR JN, Corral Del Villar C, Garcia Torres S, Araujo Zamora R, et al
    Meteorological factors and primary care consultation patterns in rheumatoid arthritis and axial spondyloarthritis: a 14-year population-based time-series study.
    Clin Rheumatol. 2026 Sep 15. doi: 10.1007/s10067-026-08415.
    >> Share

  15. MEINHARDSSON JM, Hauge EM, Klose-Jensen R, Vanden-Bossche A, et al
    Histological validation of barium-filled vascular channels detected by high-resolution peripheral quantitative computed tomography in rheumatoid arthritis: an exploratory cadaveric study.
    Clin Rheumatol. 2026 Sep 12. doi: 10.1007/s10067-026-08419.
    >> Share

  16. HARMAN H, Islek T, Dogan D, Balci MA, et al
    Paradoxical psoriasis in axial spondyloarthritis and rheumatoid arthritis treated with b/tsDMARDs: a retrospective cohort study.
    Clin Rheumatol. 2026 Sep 11. doi: 10.1007/s10067-026-08417.
    >> Share

  17. YAN J, Li Y, Su Y, Ba X, et al
    Sex and age influence the association between insulin resistance and all-cause mortality in rheumatoid arthritis patients.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08376.
    >> Share

  18. GUO W, Li B, Tian H, Guo S, et al
    Autologous hematopoietic stem cell transplantation in a patient with rheumatoid arthritis and multiple myeloma: a case-based narrative literature review.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08406.
    >> Share

  19. KISHIMOTO Y, Nakazawa K, Fukumoto Y, Kaneda R, et al
    Lower extremity osteoarthritis in elderly patients with rheumatoid arthritis: prevalence, radiographic-clinical discordance, and functional impact - a cross-sectional study.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08412.
    >> Share

  20. LI L, Li Z, Liu F, Li M, et al
    Clinical characteristics and pulmonary-cause mortality in rheumatoid arthritis-associated interstitial lung disease by lung-onset status.
    Clin Rheumatol. 2026 Sep 8. doi: 10.1007/s10067-026-08399.
    >> Share

  21. KAUR R, Satpathy S
    Comment on "AI-based CT quantification reveals small airway loss and vascular simplification in rheumatoid arthritis-associated lung disease".
    Clin Rheumatol. 2026 Sep 7. doi: 10.1007/s10067-026-08330.
    >> Share

  22. LIN Y, Qu Y, Qiu X, Huan Q, et al
    Global population-level concurrence and directional associations between rheumatoid arthritis and depressive disorders: an SDI-stratified time-series analysis using GBD 2021.
    Clin Rheumatol. 2026 Sep 5. doi: 10.1007/s10067-026-08358.
    >> Share

  23. LI Z, Cao L, Wang J, Gao X, et al
    Integrated network pharmacology and metabolomics reveal the mechanisms of Compound Nanxing Zhitong Plaster in anti-rheumatoid arthritis.
    Clin Rheumatol. 2026 Sep 3. doi: 10.1007/s10067-026-08385.
    >> Share

  24. JIAO LQ, Bian Y, Yang C, Ni S, et al
    Correlation between perivascular spaces and clinical features in patients with rheumatoid arthritis.
    Clin Rheumatol. 2026 Sep 3. doi: 10.1007/s10067-026-08383.
    >> Share

  25. IACONO D, Raimondi M, Marino V, Riccio F, et al
    Effectiveness and safety of Janus Kinase inhibitors in patients with rheumatoid arthritis, results from a multicenter observational "real-life" GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.
    Clin Rheumatol. 2026 Sep 2. doi: 10.1007/s10067-026-08373.
    >> Share

  26. WANG H, Ma Z, Wu N
    Evidence for genetic association between Hashimoto's thyroiditis and Sjogren's syndrome: a two-sample bidirectional mendelian randomization study.
    Clin Rheumatol. 2026;45:5265-5273.
    >> Share

  27. LIU Z, Chen J, Zhang Y, Lei C, et al
    Clinical characteristics and prognosis of primary Sjogren's disease patients with hypocomplementemia: reduced C3 is independently associated with new-onset peripheral cytopenias.
    Clin Rheumatol. 2026;45:5653-5666.
    >> Share

  28. ZHAO Y, Dong X, Yang P, Zhao J, et al
    Comparative Value of Traditional versus Novel Immune-Inflammatory Indices in Assessing Disease Activity of Sjogren's Disease: A Multicenter Cohort Study.
    Clin Rheumatol. 2026;45:5625-5639.
    >> Share

  29. LIU M, Su Y, Yang L, Xue H, et al
    Serum growth differentiation factor 15 as a candidate biomarker associated with interstitial lung disease in primary Sjogren's syndrome: a clinical cross-sectional study.
    Clin Rheumatol. 2026;45:5641-5651.
    >> Share

  30. ZHUANG S, Zheng L, Wang X, Pu J, et al
    The clinical characteristics and risk factors of pulmonary arterial hypertension in primary Sjogren disease: a single-center retrospective study.
    Clin Rheumatol. 2026;45:5615-5624.
    >> Share

  31. LI J, Li R, Wang W, Gesang Y, et al
    Integrated machine learning framework identifies EPSTI1 as a key diagnostic biomarker for Sjogren's disease: multi-cohort transcriptomic validation and single-cell characterization.
    Clin Rheumatol. 2026;45:5597-5613.
    >> Share

    August 2026
  32. SOYERI B, Gokcen N, Temiz Karadag D, Cefle A, et al
    Longitudinal changes in renal function in rheumatoid arthritis patients treated with biologic agents: a retrospective cohort study.
    Clin Rheumatol. 2026 Aug 29. doi: 10.1007/s10067-026-08388.
    >> Share

  33. GUARACHA-BASANEZ G, Contreras-Yanez I, Mendoza-Vigueras AV, Carvajal-Medina F, et al
    Prevalence and transient impact of childhood abuse and neglect on health-related quality of life in Mexican patients with early rheumatoid arthritis.
    Clin Rheumatol. 2026 Aug 24. doi: 10.1007/s10067-026-08370.
    >> Share

  34. LIU YY, Wang XM, Zang ZX, Yao Y, et al
    Remnant cholesterol inflammation index (RCII) as a potential biomarker for ACPA-negative rheumatoid arthritis: evidence from dual-cohort analysis and serum lipidomics.
    Clin Rheumatol. 2026 Aug 22. doi: 10.1007/s10067-026-08228.
    >> Share

  35. HWANG JH, Ryu JI
    Peripheral bone erosion and atlantoaxial instability as factors associated with pannus formation in rheumatoid arthritis: a cross-sectional risk stratification study.
    Clin Rheumatol. 2026 Aug 20. doi: 10.1007/s10067-026-08369.
    >> Share

  36. KUMAR MV, Nagalingam L, Baalann KP
    Comment on "Awareness of rheumatoid arthritis symptoms and complications among the Jordanians".
    Clin Rheumatol. 2026 Aug 20. doi: 10.1007/s10067-026-08329.
    >> Share

  37. NEVINS IS, Glas HK, Reimann F, Bos R, et al
    Real-world effectiveness of tofacitinib in monotherapy or in combination with csDMARDs in patients with rheumatoid arthritis: A collaboration between Dutch registries (TOFADUDAP study).
    Clin Rheumatol. 2026 Aug 19. doi: 10.1007/s10067-026-08362.
    >> Share

  38. ZHAO S, Jiang H, Yan Y, Wu R, et al
    Risk factors for infection in rheumatoid arthritis patients treated with tocilizumab: an observational study highlighting hydroxychloroquine use.
    Clin Rheumatol. 2026 Aug 18. doi: 10.1007/s10067-026-08357.
    >> Share

  39. PAN J, Zheng J, Wang J, Du J, et al
    Factors associated with discontinuation of bDMARDs and JAK inhibitors in patients with rheumatoid arthritis: a retrospective study.
    Clin Rheumatol. 2026 Aug 12. doi: 10.1007/s10067-026-08323.
    >> Share

  40. PAWSON M, Winchow LL, Tikly M, Govind N, et al
    Late-onset versus young-onset rheumatoid arthritis in South Africans.
    Clin Rheumatol. 2026 Aug 11. doi: 10.1007/s10067-026-08338.
    >> Share

  41. ZHENG Z, Han Y, Tang X, Zhu L, et al
    Ultrasound viscoelasticity and attenuation imaging for rheumatoid arthritis-associated muscle quality changes: a clinical transcriptomic study.
    Clin Rheumatol. 2026 Aug 7. doi: 10.1007/s10067-026-08339.
    >> Share

  42. DONG N, Xie S, Chen F, Khan A, et al
    Serum exosomal tRNA-derived small RNAs as diagnostic biomarkers for primary Sjogren's syndrome: a combined model with autoantibodies.
    Clin Rheumatol. 2026;45:4977-4991.
    >> Share

  43. EL MIEDANY Y, Elgaafary M, Plummer S, Bahlas S, et al
    Enhancing the treat-to-target approach of inflammatory arthritis with purposeful shared decision-making: results of a randomized controlled trial.
    Clin Rheumatol. 2026;45:4845-4853.
    >> Share

  44. KAMBUROGLU A, Coskun BN, Dalkilic E, Pehlivan Y, et al
    Clinical and serological predictors of autoimmune etiology in patients with interstitial lung disease: a 10-year retrospective study.
    Clin Rheumatol. 2026;45:4823-4832.
    >> Share

  45. DENIZ R, Yilmaz A, Boncukcuoglu AE, Bektas E, et al
    Real-world evidence on JAK inhibitors in rheumatology practice: comparative safety, efficacy, and outcomes between JAK inhibitors.
    Clin Rheumatol. 2026;45:4813-4822.
    >> Share

  46. BULUT GOKTEN D, Yumun Kavak F, Sogur OA, Mercan R, et al
    Coexistence of Sjogren's disease and Takayasu arteritis in a woman: a case-based review.
    Clin Rheumatol. 2026;45:5099-5103.
    >> Share

    July 2026
  47. ALHUSANI H, Katrib M, Farhat G, Merashli M, et al
    Comparative analysis of extra-articular manifestations in seronegative and seropositive rheumatoid arthritis patients: a 6-year retrospective study in a tertiary care center.
    Clin Rheumatol. 2026 Jul 31. doi: 10.1007/s10067-026-08326.
    >> Share

  48. WANG Y, Sun L, Yu R, Nie W, et al
    Janus kinase inhibitor exposure and acute coronary event patterns in rheumatoid arthritis: a treatment-aware retrospective study.
    Clin Rheumatol. 2026 Jul 24. doi: 10.1007/s10067-026-08308.
    >> Share

  49. TIAN J, Zhang J, Yang Y, Song Y, et al
    Reticuline alleviates rheumatoid arthritis by suppressing the JAK/STAT signaling pathway.
    Clin Rheumatol. 2026 Jul 22. doi: 10.1007/s10067-026-08313.
    >> Share

  50. YAN L, Zheng Y, Lin M, Ye X, et al
    Predicting the risk of bone erosion in rheumatoid arthritis using a SHAP-based interpretable machine learning model.
    Clin Rheumatol. 2026 Jul 22. doi: 10.1007/s10067-026-08289.
    >> Share

  51. LI X, Yuan J, Li C, Luo M, et al
    Development of a risk prediction model for rheumatoid arthritis-associated interstitial lung disease based on interpretable machine learning.
    Clin Rheumatol. 2026 Jul 22. doi: 10.1007/s10067-026-08293.
    >> Share

  52. TSECHELIDIS OB, Sabido-Sauri R, Attar RZ, Gazel U, et al
    Risk of misclassification of rheumatoid arthritis activity in patients with depression: a prospective ultrasound study.
    Clin Rheumatol. 2026 Jul 21. doi: 10.1007/s10067-026-08299.
    >> Share

  53. YANG K, Gao X, Deng Y, Hu J, et al
    An interpretable machine learning model integrating ultrasound and clinical variables for predicting osteoporosis in patients with rheumatoid arthritis.
    Clin Rheumatol. 2026 Jul 17. doi: 10.1007/s10067-026-08286.
    >> Share

  54. LIN Z, Ji H, Wu S, Huang Y, et al
    Adventitial root extract of oplopanax elatus alleviates rheumatoid arthritis via inhibiting NETosis.
    Clin Rheumatol. 2026 Jul 16. doi: 10.1007/s10067-026-08266.
    >> Share

  55. CHEN X, Liu S, Zhang X, Yang X, et al
    Clinical and pulmonary function-based identification of HRCT-confirmed rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2026 Jul 15. doi: 10.1007/s10067-026-08207.
    >> Share

  56. WANG X, Xu B, Wang G, Yang L, et al
    Sacral nerve stimulation modulates disease activity and autonomic function in active rheumatoid arthritis: a randomized pilot study.
    Clin Rheumatol. 2026 Jul 9. doi: 10.1007/s10067-026-08288.
    >> Share

  57. CHEN F, Tan F, Zou W, Liu J, et al
    Identification of ferroptosis hub gene cDKN1A relating to immune microenvironment in rheumatoid arthritis via bioinformatic analysis and experimental verification.
    Clin Rheumatol. 2026 Jul 9. doi: 10.1007/s10067-026-08269.
    >> Share

  58. YOO H, Kim K, Jeong J, Shin H, et al
    Sex-specific burden of osteoarthritis and rheumatoid arthritis across Asia, 1990-2023: a Global Burden of Disease Study 2023.
    Clin Rheumatol. 2026 Jul 8. doi: 10.1007/s10067-026-08280.
    >> Share

  59. KELLEY GA, Kelley KS, Huffman KM
    Effects of exercise on physical function and pain in adults with rheumatoid arthritis: an exit meta-analysis of randomized controlled trials.
    Clin Rheumatol. 2026 Jul 8. doi: 10.1007/s10067-026-08274.
    >> Share

  60. BARDAN-INCHAUSTEGUI AC, Avalos-Garcia BR, Narvaez-Gonzalez VS, Rodriguez-Garibay D, et al
    Associations between SARC-F score and FRAX score in patients with rheumatoid arthritis: A cross-sectional study.
    Clin Rheumatol. 2026 Jul 7. doi: 10.1007/s10067-026-08241.
    >> Share

  61. YANG T, Yu N, Niu Y, Yuan H, et al
    AI-based CT quantification reveals small airway loss and vascular simplification in rheumatoid arthritis-associated lung disease.
    Clin Rheumatol. 2026 Jul 6. doi: 10.1007/s10067-026-08273.
    >> Share

  62. HUANG W, Xia B, Yang H, Pan H, et al
    Association between Modified Cardiometabolic Index and rheumatoid arthritis: the mediating role of phenotypic age acceleration.
    Clin Rheumatol. 2026 Jul 6. doi: 10.1007/s10067-026-08263.
    >> Share

  63. QIU M, Nian X, Yu P, Zou S, et al
    Human epididymis protein 4: a potential prognostic biomarker for rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2026 Jul 6. doi: 10.1007/s10067-026-08265.
    >> Share

  64. PARK J, Kang ES, Jeong S
    Inverse association between metabolic dysfunction-associated steatotic liver disease and incident rheumatoid arthritis in middle-aged adults with chronic hepatitis B.
    Clin Rheumatol. 2026 Jul 3. doi: 10.1007/s10067-026-08260.
    >> Share

  65. ZHU Y, Wang Y, Feng R, Jin Y, et al
    Leukopenia and systemic features in Sjogren's disease: a retrospective hospitalized cohort study.
    Clin Rheumatol. 2026;45:4383-4390.
    >> Share

  66. WANG J, Li Y, Wang Q, He J, et al
    Usefulness of (18)F-FDG PET/CT to distinguish polymyalgia rheumatica in elderly patients presenting with myalgia.
    Clin Rheumatol. 2026;45:4583-4591.
    >> Share

  67. FEDKOV D, Yevstifeiev D, Iaremenko O, Koliadenko D, et al
    Clinical-psychosocial archetypes predict short-term outcomes in inflammatory arthritis: an unsupervised segmentation study.
    Clin Rheumatol. 2026;45:3943-3955.
    >> Share

  68. URIBE-RUIZ NA, Murillo-Baquero N, Vargas-Camacho AF, Santiago-Pacheco V, et al
    TAFRO syndrome complicating Sjogren's disease: response to subcutaneous tocilizumab.
    Clin Rheumatol. 2026;45:4667-4673.
    >> Share

    June 2026
  69. DAI LY, Ren JQ, Zhao YQ, Zhao JX, et al
    The value of arthroscopic synovectomy in the treatment of rheumatoid arthritis: A prospective cohort study.
    Clin Rheumatol. 2026 Jun 28. doi: 10.1007/s10067-026-08124.
    >> Share

  70. KOYAMA K, Ohba T, Koizumi R, Watabe K, et al
    Residual symptom absence assessed by Okomarigoto Sheet is independently associated with patient-acceptable symptom state beyond inflammation in rheumatoid arthritis.
    Clin Rheumatol. 2026 Jun 25. doi: 10.1007/s10067-026-08255.
    >> Share

  71. CHEN YJ, Ho WL, Chen HM, Chen YM, et al
    Healthcare utilization and costs in patients with rheumatoid arthritis using biologics or tofacitinib: a nationwide, population-based study.
    Clin Rheumatol. 2026 Jun 22. doi: 10.1007/s10067-026-08185.
    >> Share

  72. ZHAO Y, Guan Z, Peng L, Zhong R, et al
    Multidimensional immunoinflammatory profiles associated with rheumatoid arthritis-associated interstitial lung disease: a cross-sectional exploratory study.
    Clin Rheumatol. 2026 Jun 20. doi: 10.1007/s10067-026-08234.
    >> Share

  73. AL ZO'UBI M
    Awareness of rheumatoid arthritis symptoms and complications among the Jordanians.
    Clin Rheumatol. 2026 Jun 19. doi: 10.1007/s10067-026-08249.
    >> Share

  74. YAMASHITA Y, Maeda K, Zenitani A, Saito M, et al
    Reply to: Vertebral fractures and b/tsDMARD use in rheumatoid arthritis remission: statistical imprecision and absent fracture history data limit the interpretability of the principal finding.
    Clin Rheumatol. 2026 Jun 16. doi: 10.1007/s10067-026-08225.
    >> Share

  75. CHOUDHURI B
    Vertebral fractures and b/tsDMARD use in rheumatoid arthritis remission: statistical imprecision and absent fracture history data limit the interpretability of the principal finding.
    Clin Rheumatol. 2026 Jun 16. doi: 10.1007/s10067-026-08227.
    >> Share

  76. PARREY A, Lakshman A, Ismail M, Ashraf M, et al
    Upfront low-dose biosimilar rituximab as first biologic therapy after triple csDMARD failure in seropositive rheumatoid arthritis: a prospective real-world strategy study.
    Clin Rheumatol. 2026 Jun 13. doi: 10.1007/s10067-026-08223.
    >> Share

  77. LOIZIDIS G, Summer R
    GLP-1-based therapy and ICD-10-documented heart failure or respiratory failure events in non-diabetic adults with rheumatoid arthritis and obesity: a TriNetX federated cohort study.
    Clin Rheumatol. 2026 Jun 11. doi: 10.1007/s10067-026-08212.
    >> Share

  78. LIU J, Pan S, Xie H, He J, et al
    Machine learning-based prediction of 30-day mortality in critically ill patients with rheumatoid arthritis.
    Clin Rheumatol. 2026 Jun 8. doi: 10.1007/s10067-026-08206.
    >> Share

  79. YANG Z, Wu Y, Tian F, Bao J, et al
    Co-exposure to perchlorate, nitrate, thiocyanate, and per- and polyfluoroalkyl substances (PFAS) mixtures is associated with increased rheumatoid arthritis risk: a population-based cross-sectional study.
    Clin Rheumatol. 2026 Jun 8. doi: 10.1007/s10067-026-08213.
    >> Share

  80. NOURMOHAMMADI Z, Olfatifar M, Ahmadi MR, Motaghi R, et al
    The relationship between hematological indices of systemic inflammation and disease activity in patients with rheumatoid arthritis: a retrospective cross-sectional study.
    Clin Rheumatol. 2026 Jun 7. doi: 10.1007/s10067-026-08198.
    >> Share

  81. ZHU RC, Liu L, Wen J, Wei X, et al
    Association between thyroid peroxidase antibodies and rheumatoid arthritis: insights from genetic and population-based evidence.
    Clin Rheumatol. 2026 Jun 5. doi: 10.1007/s10067-026-08187.
    >> Share

  82. LIU Z
    Identification of potential key efferocytosis-related genes in rheumatoid arthritis using machine learning.
    Clin Rheumatol. 2026 Jun 5. doi: 10.1007/s10067-026-08190.
    >> Share

  83. ABDELLAOUI S, Al Tabaa O, Hilliquin S, d'Alessandro R, et al
    Real-world efficacy and safety profile of four JAK inhibitors in rheumatoid arthritis: a French single-center observational study.
    Clin Rheumatol. 2026 Jun 4. doi: 10.1007/s10067-026-08175.
    >> Share

  84. BANDYOPADHYAY S, Dastidar AG, Bhowmik SD, Chandra SK, et al
    Long-term effectiveness and safety of annual biosimilar Rituximab retreatment in seropositive Rheumatoid Arthritis: A 4-year real-world study.
    Clin Rheumatol. 2026 Jun 4. doi: 10.1007/s10067-026-08194.
    >> Share

  85. ANDISHGAR A, Bazmi S, Zare P, Mohammadi Z, et al
    Clinical indicators associated with pericardial effusion in rheumatoid arthritis: a machine learning-based analysis.
    Clin Rheumatol. 2026 Jun 4. doi: 10.1007/s10067-026-08196.
    >> Share

  86. LI Z, Zou T, Li Y
    Metabolic syndrome predicts cardiovascular and all-cause adverse outcomes in patients with chronic inflammatory arthritis.
    Clin Rheumatol. 2026;45:3047-3055.
    >> Share

  87. SHEN J, Gao X, Pan W, Fang Z, et al
    Metabolomics insights into RA: the proinflammatory role of phenylalanine in human FLS and primary lymphocytes.
    Clin Rheumatol. 2026;45:3203-3214.
    >> Share

  88. SHI T, Liu Q, Guo X, Wen X, et al
    Impaired pulmonary function associated with subclinical myocardial injury in primary Sjogren's syndrome: a preliminary cardiac magnetic resonance study.
    Clin Rheumatol. 2026;45:3475-3484.
    >> Share

  89. WANG X, He S, Liang X, Huang Y, et al
    Low-to-moderate dose glucocorticoids in primary Sjogren's syndrome patients on hydroxychloroquine/iguratimod therapy: a target trial emulation study.
    Clin Rheumatol. 2026;45:3485-3495.
    >> Share

  90. YILMAZ GC, Apaydin H, Erdugan M, Baltaci MA, et al
    Gender-specific patterns of glandular and extraglandular involvement in Sjogren's disease: a retrospective cohort study.
    Clin Rheumatol. 2026;45:3415-3426.
    >> Share

  91. REN T, Zhou X, Zhou E, Liu C, et al
    Elevated proportion of BST2 + CD4 + T cells: a potential biomarker for diagnosis and disease activity in Sjogren's disease.
    Clin Rheumatol. 2026;45:3459-3473.
    >> Share

  92. ZHENG J, Xu L, Zhang J, Wei J, et al
    Macrophage 2 plays an important role in axonal lesions and vasculitis in Sjogren's syndrome complicated with peripheral neuropathy.
    Clin Rheumatol. 2026;45:3427-3439.
    >> Share

  93. WANG H, Yan H, Yang M, Zhang Y, et al
    Unraveling the inflammatory bridge: genomic evidence identifies TNFRSF9 as a potential biomarker linking Sjogren's syndrome to total risk non-Hodgkin lymphoma.
    Clin Rheumatol. 2026;45:3441-3458.
    >> Share

    May 2026
  94. PLASENCIA-RODRIGUEZ C, Ortiz AM, Carmona L, Guerra-Rodriguez M, et al
    Choosing the next option: a scenario-based roadmap for b/tsDMARD sequencing in rheumatoid arthritis.
    Clin Rheumatol. 2026 May 29. doi: 10.1007/s10067-026-08172.
    >> Share

  95. ZENITANI A, Yamashita Y, Maeda K, Arakawa S, et al
    Mid-thoracic predominance and region-specific risk factors for vertebral fractures in rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2026 May 22. doi: 10.1007/s10067-026-08174.
    >> Share

  96. BAZMI S, Andishgar A, Zare P, Farjam P, et al
    Using machine learning to uncover joint involvement patterns linked to disease activity and disability in rheumatoid arthritis.
    Clin Rheumatol. 2026 May 21. doi: 10.1007/s10067-026-08176.
    >> Share

  97. HISHAM FA, Tharwat S, Nassar DK, Abdelsalam SA, et al
    Association of leptin gene polymorphisms (rs791620 and rs7799039) with rheumatoid arthritis susceptibility and clinical manifestations: a case-control study.
    Clin Rheumatol. 2026 May 18. doi: 10.1007/s10067-026-08169.
    >> Share

  98. HARAGUCHI A, Kuga T, Kaneda S, Kamo K, et al
    Foot and ankle pain is associated with subsequent daily activity limitation independent of DAS28-CRP in rheumatoid arthritis: a longitudinal cohort study.
    Clin Rheumatol. 2026 May 18. doi: 10.1007/s10067-026-08165.
    >> Share

  99. YAMASHITA Y, Maeda K, Zenitani A, Saito M, et al
    Lower odds of prevalent vertebral fractures with b/tsDMARD use among rheumatoid arthritis patients in clinical remission: a retrospective observational study.
    Clin Rheumatol. 2026 May 13. doi: 10.1007/s10067-026-08170.
    >> Share

  100. KHANMIRZAEI A, Olfatifar M, Azarinoush G, Azizkhani M, et al
    Assessing rheumatoid arthritis prevalence from 1990 to 2040: viewing global inequities through the lens of sociodemographic development.
    Clin Rheumatol. 2026 May 11. doi: 10.1007/s10067-026-08150.
    >> Share

  101. ZHANG B, Chen Q, Chen Y, Zhang H, et al
    Global burden and inequalities of rheumatoid arthritis in adults aged 15-49 years from 1990 to 2021 and projections to 2050: a cross-sectional analysis from Global Burden of Disease Study 2021.
    Clin Rheumatol. 2026 May 7. doi: 10.1007/s10067-026-08158.
    >> Share

  102. LIU C, Zhou W, Yao Z, Yu H, et al
    Lacrimal gland ultrasonography as an adjunct tool for Sjogren disease (SjD) diagnosis from undifferentiated connective tissue diseases.
    Clin Rheumatol. 2026;45:2769-2780.
    >> Share

  103. DU R, Zhang Y, Cheng F, Ge G, et al
    Novel genetic insights: Mendelian randomization implicates Felty Syndrome in atrial fibrillation risk.
    Clin Rheumatol. 2026;45:2575-2581.
    >> Share

  104. JEON HJ, Kim HS, Lee KA
    Fatigue in primary and associated Sjogren's disease: similar burden, distinct determinants.
    Clin Rheumatol. 2026;45:2759-2767.
    >> Share

  105. ALKHATIB A, Jabari D, Noaiseh G
    Sjogren's Disease and Stiff Person Syndrome: A case series highlighting a rare but significant autoimmune overlap.
    Clin Rheumatol. 2026;45:2943-2948.
    >> Share

    April 2026
  106. LIU M, Wang Y
    The neutrophil percentage-to-albumin ratio predicts all-cause and cardiovascular mortality among U.S. adults with rheumatoid arthritis: results from NHANES 1999-2010.
    Clin Rheumatol. 2026 Apr 29. doi: 10.1007/s10067-026-08141.
    >> Share

  107. HIGUCHI T, Tanaka E, Inoue E, Sugano E, et al
    Increasing proportion and more favourable outcomes of seronegative rheumatoid arthritis: analysis of the IORRA cohort from 2000 to 2021.
    Clin Rheumatol. 2026 Apr 28. doi: 10.1007/s10067-026-08139.
    >> Share

  108. ZHENG X, Ke X, Gao J, Luo X, et al
    Association between biological aging and clinical mortality among patients with rheumatoid arthritis.
    Clin Rheumatol. 2026 Apr 15. doi: 10.1007/s10067-026-08110.
    >> Share

  109. NAGAFUCHI H, Ando T, Goto Y, Kawahata K, et al
    Clinical analysis of osteonecrosis of the jaw in patients with rheumatoid arthritis: risk factors and oral health implications.
    Clin Rheumatol. 2026 Apr 15. doi: 10.1007/s10067-026-08130.
    >> Share

  110. YOU L, Li X, Luo R, Peng C, et al
    An interpretable machine learning tool for rheumatoid arthritis screening: integrating novel cellular morphological parameters with routine blood count indices.
    Clin Rheumatol. 2026 Apr 13. doi: 10.1007/s10067-026-08115.
    >> Share

  111. KUMAGAI K, Tanaka D, Nejima S, Choe H, et al
    Long-term knee function and disease activity outcomes of total knee arthroplasty in patients with rheumatoid arthritis: a retrospective study with an average 10-year follow-up.
    Clin Rheumatol. 2026 Apr 13. doi: 10.1007/s10067-026-08109.
    >> Share

  112. LIU Z, Yang F, Pan Z
    Epigenetic alterations in WDFY4 DNA methylation are linked to immunoinflammatory processes in rheumatoid arthritis: insights from a case-control study.
    Clin Rheumatol. 2026 Apr 11. doi: 10.1007/s10067-026-08116.
    >> Share

  113. ZHAO C, Yu H, Wang J, Xu K, et al
    Therapeutic effects of ginkgetin on rheumatoid arthritis: evidence from network pharmacology and experimental validation.
    Clin Rheumatol. 2026 Apr 11. doi: 10.1007/s10067-026-08113.
    >> Share

  114. ZIETEMANN V, Rudi T, Bestler D, Herzer P, et al
    Sex-specific traditional and disease-related risk factors for incident heart failure in patients with rheumatoid arthritis: a registry-based cohort study.
    Clin Rheumatol. 2026 Apr 9. doi: 10.1007/s10067-026-08078.
    >> Share

  115. CHIKANZA IC, Sakkas LI
    Potential of CAR-T cell immunotherapy in rheumatoid arthritis.
    Clin Rheumatol. 2026 Apr 8. doi: 10.1007/s10067-026-08095.
    >> Share

  116. MA H, Xu Y, Fang Y, Pan Y, et al
    Cumulative adverse social determinants of health and the odds of self-reported rheumatoid arthritis: a national study.
    Clin Rheumatol. 2026 Apr 8. doi: 10.1007/s10067-026-08104.
    >> Share

  117. WANG J, Xiao G, Huo A, Jiang H, et al
    Compared effectiveness of TNF inhibitors, JAK inhibitors, and csDMARDs in naive rheumatoid arthritis patients: a real-world, observational, multi-center, retrospective cohort study in Northwest China.
    Clin Rheumatol. 2026 Apr 8. doi: 10.1007/s10067-026-08082.
    >> Share

  118. CASTELLANOS-MOREIRA R, Frade-Sosa B, Ponce A, Rojas C, et al
    Rheumatoid arthritis initiated as palindromic rheumatism: a characteristic disease phenotype?
    Clin Rheumatol. 2026 Apr 6. doi: 10.1007/s10067-026-08059.
    >> Share

  119. OGUN H, Terlemez R, Palamar D, Akgun K, et al
    Evaluation of crystal-related arthritis in patients with knee effusion: insights from ultrasonography, microscopy and radiography.
    Clin Rheumatol. 2026;45:2319-2327.
    >> Share

  120. DONG K, Li M, Ye H, Xu Z, et al
    Elevated serum MMP3 levels as a potential biomarker of disease activity in primary Sjogren's syndrome: a prospective observational study.
    Clin Rheumatol. 2026;45:2287-2295.
    >> Share

  121. ZHANG Y, Duo R, Li Z, Liu Y, et al
    NEDD4L knockdown enhances synovial fibroblast migration, invasion, and inflammatory factor secretion via Wnt/beta-Catenin signaling activation.
    Clin Rheumatol. 2026;45:2385-2399.
    >> Share

  122. XIA N, Zhu L, Zhang W, Zhang L, et al
    Effect of ivarmacitinib on patient-reported outcomes in patients with moderate-to-severe active rheumatoid arthritis: a post-hoc analysis of a phase III trial.
    Clin Rheumatol. 2026 Apr 1. doi: 10.1007/s10067-026-08085.
    >> Share

  123. ETANI Y, Okita Y, Tsujimoto K, Noguchi T, et al
    Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.
    Clin Rheumatol. 2026 Apr 1. doi: 10.1007/s10067-026-08061.
    >> Share

  124. HUANG R, Quan S, Zeng J, Shi J, et al
    MYSM1 expression in monocytes is negatively correlated to disease activity in Rheumatoid Arthritis, which may be related to the inhibitory effect on inflammatory aging.
    Clin Rheumatol. 2026 Apr 1. doi: 10.1007/s10067-026-08090.
    >> Share

    March 2026
  125. CHENG D, Fan K, Lang X, He Y, et al
    Identification of rheumatoid arthritis manganese metabolism-related diagnostic biomarkers through bulk and single-cell RNA sequencing analysis.
    Clin Rheumatol. 2026 Mar 30. doi: 10.1007/s10067-026-08081.
    >> Share

  126. OZCELEP OF, Demir C, Okumus EC, Canli M, et al
    Combined effect of underwater ultrasound and custom-made insoles in rheumatoid arthritis: a randomized controlled trial.
    Clin Rheumatol. 2026 Mar 28. doi: 10.1007/s10067-026-08076.
    >> Share

  127. PAPAMICHAIL GV, Georgiadis NA, Xydis VG, Rapti I, et al
    Subclinical atherosclerosis in patients with undifferentiated connective tissue disease: comparison with rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 23. doi: 10.1007/s10067-026-08046.
    >> Share

  128. PARIKH A, Lewis G, GholamHosseini H, Ng KPL, et al
    Home-based respiratory-gated transcutaneous auricular vagus nerve stimulation for rheumatoid arthritis-a feasibility study.
    Clin Rheumatol. 2026 Mar 23. doi: 10.1007/s10067-026-08041.
    >> Share

  129. CRUZ-LOPEZ A, Rayo-Perez AM, Tovaruela-Carrion N, Tavara-Vidalon P, et al
    Effectiveness of physical exercise on foot pain and function in adults with rheumatoid arthritis: systematic review and meta-analysis.
    Clin Rheumatol. 2026 Mar 21. doi: 10.1007/s10067-026-08044.
    >> Share

  130. GUO R, Yang J, Zhang H, Zhang Y, et al
    Pharmacodynamic evaluation and mechanism study of cord blood nucleated cell extract in the treatment of rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 21. doi: 10.1007/s10067-026-07979.
    >> Share

  131. SONG Z, Zhu D, Sun F, Geng J, et al
    CD161(+) Treg as a potential biomarker for evaluating disease activity and treatment efficacy in rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 20. doi: 10.1007/s10067-026-08056.
    >> Share

  132. YANG M, Xu F, Zhang B, Pi H, et al
    Age-stratified treatment response in rheumatoid arthritis: a systematic review, meta-analysis, and integrated genetic and single-cell evidence implicating IL6R/TYK2 signaling.
    Clin Rheumatol. 2026 Mar 18. doi: 10.1007/s10067-026-08029.
    >> Share

  133. ZERIHUN TE, Bekalu AF, Kasaw AT, Mussie DA, et al
    Determinant of health-related quality of life among patients with rheumatoid arthritis in North West Ethiopia, 2025: a multicenter cross-sectional study.
    Clin Rheumatol. 2026 Mar 11. doi: 10.1007/s10067-026-07956.
    >> Share

  134. VEGA-MORALES D, Machado P, Bergstra SA, la Fuente WO, et al
    Global patterns and predictors of initial treatment in early rheumatoid arthritis: insights from a multinational machine learning study.
    Clin Rheumatol. 2026 Mar 9. doi: 10.1007/s10067-026-08013.
    >> Share

  135. TAKAHASHI S, Takahashi M, Shinohara M, Saegusa J, et al
    Serum beta-hydroxybutyrate as a diagnostic biomarker distinguishing acute calcium pyrophosphate crystal arthritis from rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 7. doi: 10.1007/s10067-026-08016.
    >> Share

  136. SINGH P, Parab SB, Khan A, Doshi G, et al
    Protective effects of Syringic acid on joint inflammation and damage in a rat model of rheumatoid arthritis.
    Clin Rheumatol. 2026 Mar 6. doi: 10.1007/s10067-026-08020.
    >> Share

  137. GE W, Liang C, Wang Z, Fan C, et al
    Chest muscle area, spleen density, CD4 + T%, and C4 to predict the development of interstitial lung disease in patients with Sjogren's syndrome: a clinical prediction model.
    Clin Rheumatol. 2026;45:1741-1751.
    >> Share

  138. MOCRITCAIA A, Rivero A, Frade-Sosa B, Chacur C, et al
    T-cell large granular lymphocytic leukemia associated with palindromic rheumatism: A case report.
    Clin Rheumatol. 2026;45:2067-2069.
    >> Share

  139. LIU K, Zheng Z, Chen S, Liu Y, et al
    Immune thrombocytopenia in patients with connective tissue disease.
    Clin Rheumatol. 2026;45:1637-1650.
    >> Share

  140. WANG X, He S, Liang X, Bai W, et al
    Risk factors for disease progression in primary Sjogren's syndrome patients with low disease activity: a multicenter registry-based cohort study.
    Clin Rheumatol. 2026;45:1753-1763.
    >> Share

  141. PAN S, Xie X, Li T, Wu S, et al
    IL-33/ST2 induces Tfh cells activation and GCs formation in collagen-induced arthritis.
    Clin Rheumatol. 2026;45:2035-2046.
    >> Share

    February 2026
  142. LI Y, Xu K, Liu G, Li W, et al
    Comparison of agreement between three classification criteria for early rheumatoid arthritis (ERA) in Shanxi Province of China.
    Clin Rheumatol. 2026 Feb 28. doi: 10.1007/s10067-026-07990.
    >> Share

  143. KOYAMA K, Ohba T, Koizumi R, Watabe K, et al
    Maintaining clinical remission and preventing fractures are essential for preserving functional status over a 10-year period in patients with rheumatoid arthritis who have achieved Health Assessment Questionnaire-Disability Index remission: a retrospe
    Clin Rheumatol. 2026 Feb 21. doi: 10.1007/s10067-026-07997.
    >> Share

  144. ZHENG X, Ke X, Gao J, Luo X, et al
    Association between sex-hormone binding globulin and cardiovascular events in patients with rheumatoid arthritis.
    Clin Rheumatol. 2026 Feb 14. doi: 10.1007/s10067-026-07954.
    >> Share

  145. ZHANG S, Wang H, Jin Z, Cai X, et al
    Geriatric nutritional risk index and mortality risk in elderly patients with rheumatoid arthritis: evidence from NHANES (1999-2018).
    Clin Rheumatol. 2026 Feb 13. doi: 10.1007/s10067-026-07987.
    >> Share

  146. HIDAYAT R, Fauzia F, Audrey J, Larasati AP, et al
    Gastrointestinal adverse events among methotrexate users in rheumatoid arthritis patients: a systematic review and meta-analysis.
    Clin Rheumatol. 2026 Feb 7. doi: 10.1007/s10067-026-07975.
    >> Share

  147. ZHANG F, Wang LY, Wang P, Zhang J, et al
    Global temporal trends and projections of rheumatoid arthritis incidence among women of childbearing age: age-period-cohort analysis 2021.
    Clin Rheumatol. 2026 Feb 4. doi: 10.1007/s10067-025-07912.
    >> Share

  148. POLAK D, Kolasinska M, Wilk M, Dyczek L, et al
    Sleep disorders in RA, axSpA and PsA are common despite good disease activity control-direct comparison of sleep quality and its risk factors using MDHAQ and PSQI.
    Clin Rheumatol. 2026;45:957-965.
    >> Share

  149. WU G, Shi J, Gao C, Chen Q, et al
    Deciphering the molecular landscape of Sjogren's disease, mucosa-associated lymphoid tissue lymphoma, and thyroid cancer: unraveling the complexities of disease mechanisms and diagnostic biomarkers.
    Clin Rheumatol. 2026;45:1099-1115.
    >> Share

  150. CAMPINHO FERREIRA C, Bandeira M, Pereira da Costa R, Matias S, et al
    Safety and effectiveness of rituximab therapy in Sjogren's disease: a PORTRESS - the Portuguese registry of Sjogren's disease-based study.
    Clin Rheumatol. 2026;45:1091-1098.
    >> Share

  151. LI H, Zhang Q, Shen Z, Zeng Y, et al
    Unveiling dry eye with autoimmune features (DEAF): insights from a prospective longitudinal study.
    Clin Rheumatol. 2026;45:1079-1089.
    >> Share

  152. LI N, Huang H, Jia Y, Zhao L, et al
    Relapse risk after glucocorticoid withdrawal in stable Sjogren's disease-associated interstitial lung disease: a retrospective cohort study in China.
    Clin Rheumatol. 2026;45:1069-1078.
    >> Share

  153. KOSEHASANOGULLARI M, Sen SB, Yildirim A, Bilecik NA, et al
    Effects of cognitive-motor dual-task walking on gait and pain in primary Sjogren's syndrome: a comparative cross-sectional study.
    Clin Rheumatol. 2026;45:1059-1067.
    >> Share

  154. CUI Q, Zhou B, Feng Y, Huang Q, et al
    1400 plasma metabolites and Sjogren's syndrome: a Mendelian randomization analysis.
    Clin Rheumatol. 2026;45:1045-1058.
    >> Share

  155. SUN X, Zhou Z, Zhen T, Zhou Y, et al
    Decreased salivary ZG16B expression is associated with exocrine dysfunction in Sjogren disease.
    Clin Rheumatol. 2026;45:1033-1043.
    >> Share

  156. SU QY, Wang MY, Yang L, Xue CQ, et al
    Association of Th17/Treg immune imbalance and cardiovascular complications in RA patients: retrospective cohort study in refractory subgroups.
    Clin Rheumatol. 2026;45:707-716.
    >> Share

  157. ZHANG X, Wang R, Xu M, Li Q, et al
    Analyzing the expression of hsa-miR-661 in peripheral blood mononuclear cells of patients with primary Sjogren's syndrome and its clinical significance.
    Clin Rheumatol. 2026;45:1023-1031.
    >> Share

    January 2026
  158. MORRIS NT, Woodworth T, Pham A, Elashoff DA, et al
    Rheumatoid arthritis in crisis: investigating the impact of stress on RA flares during the COVID-19 pandemic.
    Clin Rheumatol. 2026 Jan 31. doi: 10.1007/s10067-025-07754.
    >> Share

  159. HAJIALILOU N, Khabbazi A, Hajialilo M, Malek Mahdavi A, et al
    Comparing clinical outcomes of rheumatoid arthritis by onset type: palindromic rheumatism, undifferentiated arthritis, and typical rheumatoid arthritis.
    Clin Rheumatol. 2026 Jan 27. doi: 10.1007/s10067-026-07931.
    >> Share

  160. TADA M, Onishi K, Koike T, Anno S, et al
    Structural remission rate and factors associated with radiographic progression in patients with rheumatoid arthritis treated with sarilumab in clinical practice.
    Clin Rheumatol. 2026 Jan 21. doi: 10.1007/s10067-026-07944.
    >> Share

  161. PATEL SK, Meher J, Pandit VR, Samanta J, et al
    Foot and ankle arthritis in rheumatoid arthritis: prevalence and clinical correlation with disease activity.
    Clin Rheumatol. 2026 Jan 17. doi: 10.1007/s10067-026-07948.
    >> Share

  162. YEE J, Oakes EG, Santacroce L, Choi MY, et al
    Depression, anxiety, and post-traumatic stress disorder in association with cardiovascular disease among patients with systemic lupus erythematosus and rheumatoid arthritis in the All of Us Research Program.
    Clin Rheumatol. 2026 Jan 16. doi: 10.1007/s10067-026-07942.
    >> Share

  163. FU P, Zhou H, Li Y, Wang Y, et al
    Association of lipid-based insulin resistance indices with rheumatoid arthritis prevalence: a cross-sectional study from NHANES 2007-2018.
    Clin Rheumatol. 2026 Jan 13. doi: 10.1007/s10067-026-07929.
    >> Share

  164. PAN X, Cui G, Wang L, Xiao Y, et al
    The role of musculoskeletal ultrasound in differentiating gouty arthritis from rheumatoid arthritis.
    Clin Rheumatol. 2026 Jan 9. doi: 10.1007/s10067-025-07921.
    >> Share

  165. ZHANG P, Wang S, Wu T, Su Z, et al
    Association between systemic inflammatory response index and cardiovascular disease risk in rheumatoid arthritis patients: a machine learning based on US and Chinese cohorts.
    Clin Rheumatol. 2026 Jan 8. doi: 10.1007/s10067-025-07915.
    >> Share

  166. ATTAR RZ, Chu R, Humphrey-Murto S, Mansour S, et al
    When it's not RA: unmasking Whipple's disease in seronegative, difficult-to-treat rheumatoid arthritis.
    Clin Rheumatol. 2026 Jan 2. doi: 10.1007/s10067-025-07886.
    >> Share

  167. BOURGUIBA R, Bellakhal S, Boudokhane M, Helali W, et al
    Usefulness of salivary gland ultrasonography in Sjogren's syndrome: The Tunisian Experience.
    Clin Rheumatol. 2026;45:251-255.
    >> Share

  168. LIU Z, Yang Y, Liu S, Zhang G, et al
    Initial assessment of blood-brain barrier permeability alterations and associated clinical characteristics in patients with primary Sjogren's syndrome: Insights from DCE-MRI.
    Clin Rheumatol. 2026;45:329-341.
    >> Share

  169. AJDER M, Cansu DU, Colak E, Teke HU, et al
    Etiologic spectrum and early mortality predictors in extreme hyperferritinemia: insights from rheumatology and hematology clinics.
    Clin Rheumatol. 2026;45:531-540.
    >> Share

  170. LEE KA, Kim YH, Kim HS
    Diagnostic concordance and added value of doppler ultrasound and extended histopathologic features in primary Sjogren disease.
    Clin Rheumatol. 2026;45:319-327.
    >> Share

  171. HAN F, Gao R, Fan H, Pu J, et al
    Telomere length in leukocyte as biomarker for diagnosis of primary Sjogren's syndrome: a cross-sectional study.
    Clin Rheumatol. 2026;45:309-318.
    >> Share

  172. JUNFEI Z, Zhen Z, Fu Q, Meihua G, et al
    Identification of five novel hub genes associated with interstitial lung disease in primary Sjogren's syndrome via transcriptome sequencing.
    Clin Rheumatol. 2026;45:291-307.
    >> Share

  173. GROENER M, Baker H, Danve A
    VEXAS syndrome presenting with features of Sjogren's disease: a case-based review of VEXAS and autoimmune disease overlap.
    Clin Rheumatol. 2026;45:541-548.
    >> Share

  174. MO Y, Yang W, Li Y, Dai L, et al
    Clinical practice guideline for the treatment of Sjogren's disease through off-label drug use in China (English edition).
    Clin Rheumatol. 2026;45:257-269.
    >> Share

    December 2025
  175. MUTTIAH B, Wahab AA
    Cellular stress, cell death, and extracellular vesicles: redefining the therapeutic landscape of rheumatoid arthritis.
    Clin Rheumatol. 2025 Dec 24. doi: 10.1007/s10067-025-07887.
    >> Share

  176. ZHOU M, Zhu H, Zhang L, Huo Y, et al
    Disparities in clinical characteristics and health-related quality of life among young, young-onset elderly and elderly-onset rheumatoid arthritis patients: A large-scale national survey.
    Clin Rheumatol. 2025 Dec 22. doi: 10.1007/s10067-025-07895.
    >> Share

  177. SHABBIR AA, Afaq M, Mohsin O, Anvery SFA, et al
    Vagus nerve stimulation: a novel approach for refractory rheumatoid arthritis.
    Clin Rheumatol. 2025 Dec 18. doi: 10.1007/s10067-025-07875.
    >> Share

  178. REN H, Ding N, Yu X, Teng J, et al
    Single high-dose intramuscular injection versus short-term low-dose oral glucocorticoids as bridging therapy in active rheumatoid arthritis: a retrospective cohort study on remission induction.
    Clin Rheumatol. 2025 Dec 16. doi: 10.1007/s10067-025-07854.
    >> Share

  179. YUAN J, Liu WZ, Wu DC, Jia FY, et al
    Non-linear association of admission platelet-to-lymphocyte ratio with 28- and 90-day mortality in critically ill patients with rheumatoid arthritis: a retrospective cohort study.
    Clin Rheumatol. 2025 Dec 9. doi: 10.1007/s10067-025-07853.
    >> Share

  180. SCHNEEBERGER EE, Perandones M, Rosemffet MG, Otaola M, et al
    Correction: Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Dec 5. doi: 10.1007/s10067-025-07844.
    >> Share

  181. SCHNEEBERGER EE, Felquer MLA, Citera G, Soriano E, et al
    Correction: Long-term persistence of biological agents in the treatment of patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
    Clin Rheumatol. 2025 Dec 3. doi: 10.1007/s10067-025-07839.
    >> Share

  182. SEO S, Cortinas MCB
    The impact of 24-h occupational stress on C-reactive protein and pain in a patient with rheumatoid arthritis: a 40-day prospective case study and literature review.
    Clin Rheumatol. 2025 Dec 2. doi: 10.1007/s10067-025-07859.
    >> Share

  183. JIN J, Jin Y, He J
    From endotypes to therapeutic targets: exploring the potential of precision treat-to-target approaches in primary Sjogren's disease.
    Clin Rheumatol. 2025;44:4797-4805.
    >> Share

  184. COUTINHO GC, Romao VC, Coutinho JC, Simao R, et al
    Corticosteroid irrigation of parotid glands for oral dryness in Sjogren's and non-Sjogren's sicca disease: a longitudinal study.
    Clin Rheumatol. 2025;44:4965-4974.
    >> Share

  185. LIANG H, Long M, Tie S, Dong S, et al
    Clinical characteristics and risk factors for the bidirectional association between immune thrombocytopenia and Sjogren's syndrome.
    Clin Rheumatol. 2025;44:4955-4963.
    >> Share

    November 2025
  186. WANG Q, Yin J, Zhang M, Jia X, et al
    Letter to the editor: Inflammatory cytokines mediate the common genetic and immunological background between rheumatoid arthritis and osteoporosis.
    Clin Rheumatol. 2025 Nov 29. doi: 10.1007/s10067-025-07821.
    >> Share

  187. QIAN B, Fang Z
    The association between oral microbiome diversity and rheumatoid arthritis: a nationwide cross-sectional study.
    Clin Rheumatol. 2025 Nov 22. doi: 10.1007/s10067-025-07835.
    >> Share

  188. ANGELOUDI E, Anyfanti P, Gavriilaki E, Pagkopoulou E, et al
    Asymmetric dimethylarginine and vascular injury in rheumatoid arthritis, from capillaries to large vessels: results from a cross-sectional study.
    Clin Rheumatol. 2025 Nov 22. doi: 10.1007/s10067-025-07816.
    >> Share

  189. LEI J, Wen Y, Li L, Ji H, et al
    High glucose-induced mitophagy accelerates premature aging of T cells in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Nov 20. doi: 10.1007/s10067-025-07815.
    >> Share

  190. VAN SOEST K, Ramiro S, Starmans-Kool MJF, Punt NC, et al
    Cost optimizing tocilizumab therapy in stable rheumatoid arthritis: a dose de-escalation nomogram to prevent overuse and unnecessary costs.
    Clin Rheumatol. 2025 Nov 13. doi: 10.1007/s10067-025-07796.
    >> Share

  191. ZHOU J, Dou X, Wu X, Li Y, et al
    Inflammatory cytokines mediate the common genetic and immunological background between rheumatoid arthritis and osteoporosis.
    Clin Rheumatol. 2025 Nov 7. doi: 10.1007/s10067-025-07693.
    >> Share

  192. ANDERSSON MLE, Wibring K, Bergman S, Bremander A, et al
    Empowerment as the key to health-enhancing physical activity in patients with rheumatoid arthritis and low physical function-a cross-sectional study.
    Clin Rheumatol. 2025 Nov 3. doi: 10.1007/s10067-025-07696.
    >> Share

  193. TENG HE, Tsai YH, Mo YC, Lu YJ, et al
    Elevated levels of nitrotyrosine-modified protein adducts and their association with the severity of primary sjogren's syndrome and secondary sjogren's syndrome with rheumatoid arthritis in Taiwanese Patients.
    Clin Rheumatol. 2025 Nov 1. doi: 10.1007/s10067-025-07730.
    >> Share

  194. YUAN M, Zhou Y, Long Z, Peng Y, et al
    Shared genetic architecture and potential comorbid mechanisms between rheumatoid arthritis and idiopathic pulmonary fibrosis.
    Clin Rheumatol. 2025 Nov 1. doi: 10.1007/s10067-025-07774.
    >> Share

  195. SAPUNDZHIEVA T, Sapundzhiev L, Karalilova R, Batalov A, et al
    Disease activity score for twenty-eight joints reflects different distribution of the inflammation as seen on ultrasound: A comparative ultrasound study in early rheumatoid and psoriatic arthritis.
    Clin Rheumatol. 2025;44:4727-4737.
    >> Share

  196. ASGHARVAND-HAJEB A, Shahmohammadi-Farid S, Saberivand M, Safary A, et al
    Molecular analysis of TNFAIP3, PTPN22, IRF5, and IL-10 gene polymorphisms in palindromic rheumatism.
    Clin Rheumatol. 2025;44:4759-4766.
    >> Share

  197. JIANG S, Dong Y, Wang Z, Liang M, et al
    Identification of shared diagnostic biomarkers and potential co-morbidity mechanisms between primary Sjogren's syndrome and chronic kidney disease.
    Clin Rheumatol. 2025;44:4577-4589.
    >> Share

  198. CORTES JS, Carvajal W, Correa A, Veloza K, et al
    Agreement between glandular ultrasonography and histopathology of minor salivary glands in adults with sicca syndrome.
    Clin Rheumatol. 2025;44:4567-4576.
    >> Share

    October 2025
  199. TADA M, Matsumoto Y, Koike T, Mamoto K, et al
    Biological/targeted synthetic disease-modifying antirheumatic drugs improve not only muscle mass but also phase angle in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Oct 31. doi: 10.1007/s10067-025-07767.
    >> Share

  200. EDITH SE, Laura AFM, Gustavo C, Enrique S, et al
    Long-term persistence of biological agents in the treatment of patients with rheumatoid arthritis: a systematic literature review and meta-analysis.
    Clin Rheumatol. 2025 Oct 29. doi: 10.1007/s10067-025-07700.
    >> Share

  201. MALDONADO-CANON K, Coral-Alvarado P, Mendez-Patarroyo P, Bautista-Molano W, et al
    ANAs and triple positivity effect on disease activity and sustained remission in rheumatoid arthritis: a retrospective real-world machine learning approach.
    Clin Rheumatol. 2025 Oct 24. doi: 10.1007/s10067-025-07683.
    >> Share

  202. XU J, Gong Y, Ding L, Luo Y, et al
    AIM2 as an Immunogenic Cell Death (ICD)-related hub gene in rheumatoid arthritis: identification and functional validation.
    Clin Rheumatol. 2025 Oct 20. doi: 10.1007/s10067-025-07728.
    >> Share

  203. SHORTER E, Ossipova E, Alves ES, Idborg H, et al
    Health-enhancing physical activity induce beneficial skeletal muscle mitochondrial adaptations in individuals with rheumatoid arthritis.
    Clin Rheumatol. 2025 Oct 20. doi: 10.1007/s10067-025-07734.
    >> Share

  204. AKALTUN MS, Balbal E, Altindag O, Gur A, et al
    Ultrasonographic measurement of talar cartilage thickness in patients with rheumatoid arthritis and healthy controls.
    Clin Rheumatol. 2025 Oct 11. doi: 10.1007/s10067-025-07722.
    >> Share

  205. CUI M, Zhang C, Zhou Q, Ji M, et al
    Association of Apolipoprotein E polymorphism with lipoprotein metabolism and cardiovascular disease risk in rheumatoid arthritis patients.
    Clin Rheumatol. 2025 Oct 10. doi: 10.1007/s10067-025-07733.
    >> Share

  206. LIU X, Yuan PY, Zhang GH, Bu LH, et al
    The interactions between HLA alleles and immune indicators were associated with the risk of rheumatoid arthritis.
    Clin Rheumatol. 2025 Oct 8. doi: 10.1007/s10067-025-07729.
    >> Share

  207. ZHAO P, Song S, Cheng W, Peng C, et al
    Reduced TIGIT(+)CD56(+)NK cells associate with disease progression and impaired immune regulation in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:4119-4131.
    >> Share

  208. LIU Y, Wang Q, Zhang Y, Duo R, et al
    Multi-omics characterization of gut microbiota and fecal and plasma metabolites in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:4103-4118.
    >> Share

  209. LI RC, Liu XY, Fu L, Lan YY, et al
    Risk factors in systemic lupus erythematosus-associated Sjogren's syndrome: multicenter case-control studies and systematic review.
    Clin Rheumatol. 2025;44:4091-4101.
    >> Share

  210. WANG R, Wu J, Han Y, Zang S, et al
    Exploring gender-related clinical and immunological profiles in Sjogren's disease in a Chinese cohort.
    Clin Rheumatol. 2025;44:4081-4090.
    >> Share

  211. ANDREASSON S, Sodergren A
    Prevalence of metabolic syndrome and its components in psoriatic arthritis compared with general population, cutaneous psoriasis, and other inflammatory arthropathies: a meta-analysis.
    Clin Rheumatol. 2025;44:3787-3799.
    >> Share

  212. ZHONG G, Zhang C, Xie W, Ding X, et al
    Clinical Characteristics, Imaging Patterns and Management in Male and Female Patients with Primary Sjogren's Syndrome-associated Interstitial Lung Disease.
    Clin Rheumatol. 2025;44:4071-4080.
    >> Share

  213. WANG Q, Zhang Y, Zhang H, Chen Z, et al
    Suboptimal methotrexate utilization in Chinese patients with inflammatory arthritis: data from a Chinese center.
    Clin Rheumatol. 2025;44:3829-3833.
    >> Share

    September 2025
  214. LAI SW, Kuo YH, Liao KF
    Association between rheumatoid arthritis and thyroid cancer risk: a real-world cohort study using TriNetX.
    Clin Rheumatol. 2025 Sep 29. doi: 10.1007/s10067-025-07668.
    >> Share

  215. WANG Q, Anthony DD
    Glucagon-like peptide-1 receptor analog use is associated with reduced thromboembolic events compared with dipeptidyl peptidase-4 inhibitors in rheumatoid arthritis patients: A global retrospective cohort study.
    Clin Rheumatol. 2025 Sep 27. doi: 10.1007/s10067-025-07709.
    >> Share

  216. RODRIGUES LSS, Feyo VB, Provinciali LS, Pereira JJ, et al
    Association between tooth loss and clinical complications in rheumatoid arthritis: a pilot study.
    Clin Rheumatol. 2025 Sep 23. doi: 10.1007/s10067-025-07647.
    >> Share

  217. SALIEVA RS, Zhumabaeva S, Isakov U, Sakibaev K, et al
    The role of sequential biologic therapy in rheumatoid arthritis: a systematic review and meta-analysis of efficacy, safety, and predictive factors.
    Clin Rheumatol. 2025 Sep 11. doi: 10.1007/s10067-025-07636.
    >> Share

  218. ZHU K, Zhang X, Chen G, Zhu Y, et al
    Treatment effectiveness of hydroxychloroquine in patients with primary Sjogren's syndrome: a real-world Study.
    Clin Rheumatol. 2025;44:3591-3603.
    >> Share

  219. HUI M, Deng X, Wang J, Qian J, et al
    The association between STAT4 polymorphism and pulmonary arterial hypertension in Chinese patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:3581-3590.
    >> Share

    August 2025
  220. PRASAD CB, Dhir V, Gupta R, Thomas KN, et al
    Split vs single-dose oral methotrexate in rheumatoid arthritis: a randomized controlled trial (SMART study).
    Clin Rheumatol. 2025 Aug 29. doi: 10.1007/s10067-025-07646.
    >> Share

  221. AL-JEDAI A, Al-Mudaiheem H, Alghanim N, Alhomood I, et al
    Transforming rheumatoid arthritis care: dynamic budget impact models with ACR to DAS28 mapping for anti-TNFs, JAK inhibitors, and interleukins.
    Clin Rheumatol. 2025 Aug 21. doi: 10.1007/s10067-025-07644.
    >> Share

  222. YIN J, Zhang M, Jia X
    Letter to the editor: clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 19. doi: 10.1007/s10067-025-07660.
    >> Share

  223. SUNNER S, Jones B, Jones CA, Al Hamarneh YN, et al
    Age-related disparities in biologic therapy initiation among rheumatoid arthritis patients: Insights from a large retrospective cohort study.
    Clin Rheumatol. 2025 Aug 12. doi: 10.1007/s10067-025-07615.
    >> Share

  224. LU YC, Chen YC
    Ultrasound of the wrist in low disease rheumatoid arthritis patients: Intercarpal joint is more sensitive than radio-carpal and distal radio-ulnar joint.
    Clin Rheumatol. 2025 Aug 6. doi: 10.1007/s10067-025-07625.
    >> Share

  225. CAI T, Tao Y, Pan Q, Yang L, et al
    Integrative GWAS and Mendelian randomization study of rheumatoid arthritis based on the 2019 UK Biobank questionnaire.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07590.
    >> Share

  226. LI S, Zhang J, Li J, Liu W, et al
    Nonlinear association between rheumatoid factor and interstitial lung disease risk in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Aug 5. doi: 10.1007/s10067-025-07627.
    >> Share

  227. ZHANG Y, Liang Y, Liu M, Liu L, et al
    Identifying plasma proteins and immunocyte phenotypes as risk factors in rheumatoid arthritis: The role of EPHA3 and CD28(+) CD45RA(+) CD8(br) treg cells.
    Clin Rheumatol. 2025 Aug 2. doi: 10.1007/s10067-025-07605.
    >> Share

  228. DOZET M, Fugosic Mesic V, Laskarin AM, Drvar V, et al
    Salivary and serum biomarkers profile of patients with rheumatoid arthritis and temporomandibular disorders.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07593.
    >> Share

  229. ANYFANTI P, Antza C, Ainatzoglou A, Angeloudi E, et al
    Sodium, potassium intake and urinary sodium-to-potassium ratio in rheumatoid arthritis: association with markers of cardiovascular dysfunction and disease-related parameters.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07608.
    >> Share

  230. KOYAMA K, Ohba T, Koizumi R, Haro H, et al
    Prevalence and Predictors of Residual Symptoms in Rheumatoid Arthritis Patients in SDAI Remission: A Cross-Sectional Study Using the Illustrated Okomarigoto Sheet.
    Clin Rheumatol. 2025 Aug 1. doi: 10.1007/s10067-025-07592.
    >> Share

    July 2025
  231. RAO P, Jin S, Zhang B, Li R, et al
    Synovial infiltrating immune cell heterogeneity associated with synovitis severity and systemic disease activity in rheumatoid arthritis: a cross-sectional study.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07565.
    >> Share

  232. KOMIYA Y, Sugihara T, Ishizaki T, Kimura N, et al
    The impact of aging and glucocorticoid use on physical function of older rheumatoid arthritis in remission: analysis of a National Database of Rheumatic Disease in Japan.
    Clin Rheumatol. 2025 Jul 30. doi: 10.1007/s10067-025-07599.
    >> Share

  233. ZHA X, Liu M, Ruan S, Jiang Y, et al
    Relationship between serum vitamin D levels and pro-inflammatory cytokines in patients with rheumatoid arthritis combined with cardiovascular disease.
    Clin Rheumatol. 2025 Jul 26. doi: 10.1007/s10067-025-07587.
    >> Share

  234. MAS MARIN J, Molina-Olano M, Sola NR, Miserachs-Aranda N, et al
    Biosimilars and reference biological medicines in the treatment of rheumatoid arthritis: a multicenter cross-sectional study in Catalonia, Spain.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07568.
    >> Share

  235. TUZUN Z, Aydin K, Turk I, Varkal G, et al
    Evaluation of the coalescent lung ultrasound score in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 Jul 24. doi: 10.1007/s10067-025-07589.
    >> Share

  236. LI Z, Liu Y, Zhang Y, Zhang Z, et al
    NETs promote fibroblast-like synoviocytes producing IL-6 to enhance T follicular helper cell response in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07543.
    >> Share

  237. HUANG J, Wang L, Hu X, Wang T, et al
    Genetic and molecular underpinnings of the link between rheumatoid arthritis and myasthenia gravis: Insights from GWAS and transcriptomic analyses.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07582.
    >> Share

  238. OZ B, Dogan Y, Karatas A, Koca SS, et al
    Radiological and serological predictors of cavitary transformation in rheumatoid arthritis-associated pulmonary nodules: a retrospective cohort study.
    Clin Rheumatol. 2025 Jul 19. doi: 10.1007/s10067-025-07579.
    >> Share

  239. ZOU L, Fan Q, Liu Y, He H, et al
    Leucine-rich alpha-2-glycoprotein 1 (LRG1) decrement during biologics therapy and its correlation with disease features and treatment outcomes in rheumatoid arthritis patients.
    Clin Rheumatol. 2025 Jul 15. doi: 10.1007/s10067-025-07545.
    >> Share

  240. REN Y, Xia W, Wu J, Yang Z, et al
    Artificial intelligence-based prediction of organ involvement in Sjogren's syndrome using labial gland biopsy whole-slide images.
    Clin Rheumatol. 2025;44:2919-2927.
    >> Share

  241. CHENG F, Wang YL, Ai XY, Liu Y, et al
    Clinical features of anti-RNP-positive primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2911-2917.
    >> Share

  242. TURKMEN S, Coskuner T, Sozeri B
    Multidimensional assessment of Juvenile Sjogren disease.
    Clin Rheumatol. 2025;44:2897-2909.
    >> Share

  243. GU X, Chen Y, Xuan J, Shi Y, et al
    Positive thyroid autoantibodies in primary Sjogren syndrome define a subset of patients with milder disease.
    Clin Rheumatol. 2025;44:2889-2895.
    >> Share

  244. JONUSIENE G, Kaceniene A, Gedvilaite V, Dadoniene J, et al
    Cancer risk in patients with Sjogren's syndrome in Lithuanian cohort study.
    Clin Rheumatol. 2025;44:2883-2887.
    >> Share

    June 2025
  245. EDITH SE, Miguel P, Gabriel RM, Maria O, et al
    Clinical variables and lung ultrasonography for the screening of interstitial lung disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 24. doi: 10.1007/s10067-025-07510.
    >> Share

  246. AKBARI AR, Alam B
    Medication effects on uric acid levels in rheumatoid arthritis studies.
    Clin Rheumatol. 2025 Jun 20. doi: 10.1007/s10067-025-07538.
    >> Share

  247. JIN J, Xiang X, Cai X, Hou Y, et al
    Machine learning and bioinformatics analysis to identify and validate diagnostic model associated with immune infiltration in rheumatoid arthritis.
    Clin Rheumatol. 2025 Jun 11. doi: 10.1007/s10067-025-07514.
    >> Share

  248. KARACAOGLU MC, Kizildag B, Okyar B, Yildirim Cetin G, et al
    Computed tomography-based quantitative scoring system for rheumatoid arthritis-associated interstitial lung disease: a retrospective diagnostic accuracy study for progressive fibrosis detection.
    Clin Rheumatol. 2025 Jun 9. doi: 10.1007/s10067-025-07511.
    >> Share

  249. OSKEN S, Osken A, Polat F, Sahin D, et al
    A retrospective study of electrocardiographic alterations in primary Sjogren's syndrome: role of anti-SSA positivity and disease duration.
    Clin Rheumatol. 2025;44:2377-2386.
    >> Share

  250. SU R, Wang H, Li B, Wu R, et al
    Low-dose IL-2 restores Tfh/Tfr imbalance and modulates B cell subset distribution in the pre-arthritis phase of the collagen-induced arthritis model.
    Clin Rheumatol. 2025;44:2487-2500.
    >> Share

  251. QI X, Zhao D, Wang N, Han Y, et al
    B lymphocyte subset-based stratification in primary Sjogren's syndrome: implications for lymphoma risk and personalized treatment.
    Clin Rheumatol. 2025;44:2403-2412.
    >> Share

  252. DOU H, Wu R, Wang H, Wang X, et al
    CCR5 + T cells as a potential biomarker for primary Sjogren's disease based on bioinformatics analysis.
    Clin Rheumatol. 2025;44:2387-2401.
    >> Share

  253. LUO Y, Mo Y, Li S, Yao J, et al
    Value of combined application of the OMERACT scoring system and shear wave elastography for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2367-2375.
    >> Share

  254. FAN R, Zhang Z, Huang Q, Liu L, et al
    Association of regional adiposity distribution with risk of autoimmune diseases.
    Clin Rheumatol. 2025;44:2541-2552.
    >> Share

  255. WANG C, Hu H, Xu Y, Wang S, et al
    Transcriptomic sequencing of multiple salivary glands combined with bioinformatics analysis reveals key genes in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:2355-2365.
    >> Share

  256. WANG Z, Chen X, Zhang QB, Wang H, et al
    Exploring the genetic components and multi-omics sources of inflammatory bowel disease from the perspective of autoimmune disorders.
    Clin Rheumatol. 2025;44:2527-2539.
    >> Share

  257. DUO R, Wang Y, Ma Q, Wang X, et al
    MTX-induced gastrointestinal reactions in RA: Prevotella enrichment, gut dysbiosis, and PI3K/Akt/Ras/AMPK pathways.
    Clin Rheumatol. 2025;44:2163-2177.
    >> Share

    May 2025
  258. MUSTONEN AM, Savinainen J, Lehtonen M, Lehenkari P, et al
    Synovial fluid o-tyrosine is a potential biomarker for autoimmune-driven rheumatoid arthritis.
    Clin Rheumatol. 2025 May 31. doi: 10.1007/s10067-025-07491.
    >> Share

  259. RAO P, Jin S, Qi Y, Liu X, et al
    Clinical significance of serum RAGE levels in anti-CCP-negative rheumatoid arthritis.
    Clin Rheumatol. 2025 May 22. doi: 10.1007/s10067-025-07493.
    >> Share

  260. YAN L, Xu J, Ye X, Lin M, et al
    Development and validation of ultrasound-based radiomics deep learning model to identify bone erosion in rheumatoid arthritis.
    Clin Rheumatol. 2025 May 19. doi: 10.1007/s10067-025-07481.
    >> Share

  261. ZHENG X, Ke X, Gao J, Zheng Z, et al
    The molecular basis of all-trans retinoic acid binding to the target genes involved in rheumatoid arthritis through network pharmacology and molecular docking.
    Clin Rheumatol. 2025 May 17. doi: 10.1007/s10067-025-07482.
    >> Share

  262. WU T, Wang Y, Xia Y, Ji J, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of infectious diseases.
    Clin Rheumatol. 2025 May 16. doi: 10.1007/s10067-025-07485.
    >> Share

  263. PHAM TH, Do TTH, Nguyen TN, Luu LC, et al
    Characteristics of sarcopenia in patients with rheumatoid arthritis at a central university hospital in Hanoi, Vietnam: a cross-sectional study.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07469.
    >> Share

  264. TEMIZ KARADAG D, Dogan S, Cakir O, Altintas Y, et al
    The potential of semi-quantitative and quantitative methods in predicting progression in rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2025 May 15. doi: 10.1007/s10067-025-07443.
    >> Share

  265. GOMES-SILVA JM, Torres CP, Teixeira LR, Saraiva MDCP, et al
    Prospective Sham-Controlled trial: acupuncture for symptom-relieving in patients with Sjogren's disease.
    Clin Rheumatol. 2025;44:1971-1982.
    >> Share

  266. LI X, Li Y, Luo Q, Yang W, et al
    Direct immunofluorescence of labial gland in diagnosis of Sjogren's disease.
    Clin Rheumatol. 2025;44:1961-1969.
    >> Share

  267. YANG Y, Zhang Y, Liu K, Liu M, et al
    IFI27, a potential candidate molecular marker for primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1949-1960.
    >> Share

    April 2025
  268. XU QY, Liu YQ, Tong WQ, Yin-Ruo YR, et al
    Comparison of the clinical efficacy and pharmacoeconomics of tofacitinib and adalimumab in Chinese patients with rheumatoid arthritis: An analysis based on propensity score matching.
    Clin Rheumatol. 2025 Apr 29. doi: 10.1007/s10067-025-07431.
    >> Share

  269. MA Z, Wu S, Xiong LE, Zhong J, et al
    Interaction of nutritional and inflammatory levels on all-cause mortality among individuals with rheumatoid arthritis: a prospective cohort study.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07458.
    >> Share

  270. YANG D, Chen J, He G, Zhou Z, et al
    Comparisons of [(68) Ga]Ga-FAPI-04 PET/CT with X-ray imaging in the assessment of patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07414.
    >> Share

  271. ZHAO P, Yuan K, Tang Z, Li Y, et al
    Investigation of hub-shared genes and regulatory mechanisms of rheumatoid arthritis and atherosclerosis.
    Clin Rheumatol. 2025 Apr 28. doi: 10.1007/s10067-025-07423.
    >> Share

  272. MALEKAN M, Dozandeh-Jouybari A, Sadeghian N, Soltanshahi M, et al
    SLAM receptors regulate immune checkpoints via SAP and EAT- 2 in rheumatoid arthritis: association with disease activity.
    Clin Rheumatol. 2025 Apr 26. doi: 10.1007/s10067-025-07461.
    >> Share

  273. WU Q, Zhang X, Qin M, Shi D, et al
    Dual roles of LncRNA RNA143598: a biomarker for rheumatoid arthritis and its implications in cancer.
    Clin Rheumatol. 2025 Apr 25. doi: 10.1007/s10067-025-07448.
    >> Share

  274. CELIK NC, Kilinc EA
    Assessment of ChatGPT's adherence to EULAR diagnostic criteria and therapeutic protocols for rheumatoid arthritis at two distinct time points, 14 days apart, utilizing binary and multiple-choice inquiries.
    Clin Rheumatol. 2025 Apr 22. doi: 10.1007/s10067-025-07417.
    >> Share

  275. THYBERG I, Husberg M, Kastbom A
    Physical and mental disability is evident 8 years after diagnosis in early rheumatoid arthritis despite contemporary medication and non-pharmacological interventions.
    Clin Rheumatol. 2025 Apr 9. doi: 10.1007/s10067-025-07399.
    >> Share

  276. LEBOUILLE-VELDMAN AB, Huizinga TWJ, Mekary RA, Vleggeert-Lankamp CLA, et al
    Prolonged glucocorticoid use and rheumatoid arthritis-associated cervical spine deformity.
    Clin Rheumatol. 2025 Apr 4. doi: 10.1007/s10067-025-07408.
    >> Share

  277. YANG J, Park Y, Lee JJ, Kim WU, et al
    Clinical value of salivary gland ultrasonography in evaluating secretory function, disease activity, and lymphoma risk factors in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1643-1652.
    >> Share

  278. HAKBILEN S, Tezcan D, Onmaz DE, Yilmaz S, et al
    The role of CXCL9, CXCL10, and CXCL13 chemokines in patients with Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1635-1642.
    >> Share

  279. HAN Y, Wang R, Sun F, Feng R, et al
    Anti-SSA/SSB antibody double-negative Sjogren's disease patients: a comprehensive clinical study and immune profile.
    Clin Rheumatol. 2025;44:1625-1633.
    >> Share

  280. XU Y, Yin Y, Li W, Zhou J, et al
    Salvage treatment of AOSD-associated macrophage activation syndrome with bariticinib following conventional immunosuppressive therapy.
    Clin Rheumatol. 2025;44:1705-1712.
    >> Share

    March 2025
  281. GENG L, Li T, Liu Y, Liu X, et al
    Lycium barbarum polysaccharide corrects CCR9(+) Th17/ Treg imbalance in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 27. doi: 10.1007/s10067-025-07415.
    >> Share

  282. LI F, Xian D, Yang K
    Mendelian randomization and mediation analysis reveal the role of immune cell subsets in the causal pathways between blood cell perturbation responses and rheumatoid arthritis.
    Clin Rheumatol. 2025 Mar 12. doi: 10.1007/s10067-025-07387.
    >> Share

  283. ANGELOZZI L, Gillibert A, Brevet P, Grosjean J, et al
    Comparative analysis of clinical profile, therapeutic management, and clinical prognosis of patients with seropositive or seronegative rheumatoid arthritis following the introduction of a first targeted therapy in a real-life setting.
    Clin Rheumatol. 2025 Mar 10. doi: 10.1007/s10067-025-07390.
    >> Share

  284. ZHAO C, Xiao Q, Huang W, Chen Y, et al
    Association between rheumatoid arthritis and hyperuricemia among adults: a cross-sectional study based on NHANES data.
    Clin Rheumatol. 2025 Mar 6. doi: 10.1007/s10067-025-07386.
    >> Share

  285. YU X, Xi J, Wu J, Song R, et al
    Correlation between myocardial work and disease activity in rheumatoid arthritis patients with preserved left ventricular ejection fraction: a retrospective study based on non-invasive pressure-strain loop?.
    Clin Rheumatol. 2025 Mar 5. doi: 10.1007/s10067-025-07380.
    >> Share

  286. SONG S, Yang Y, Ren T, Shen Y, et al
    Enhanced co-expression of TIGIT and PD-1 on gammadelta T cells correlates with clinical features and laboratory parameters in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1245-1257.
    >> Share

  287. PEI W, Xu L, Zhong H, Wang Z, et al
    Clinical features of inflammatory arthritis in daily practice-China's perspective.
    Clin Rheumatol. 2025;44:969-978.
    >> Share

  288. LIANG Y, Zhang Z, Li J, Yang Z, et al
    Association of increased serum I-309 with phenotypes, disease activity, and cytokine pattern in primary Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1237-1243.
    >> Share

  289. HUGHES DM, Yiu ZZN, Zhao SS
    External validation of the accuracy of cardiovascular risk prediction tools in psoriatic disease: a UK Biobank study.
    Clin Rheumatol. 2025;44:1151-1161.
    >> Share

  290. PANG F, Jiang Q, Tang X, Li K, et al
    Fecal metabolomic analysis of the role of gut microbiota and short-chain fatty acids in the therapeutic mechanism of Timosaponin AIII in Sjogren's syndrome.
    Clin Rheumatol. 2025;44:1209-1223.
    >> Share

  291. LIANG P, Huang Y, Hu Z, Zhou L, et al
    Clinical and laboratory characteristics of Sjogren's syndrome-associated autoimmune liver disease: a real-world, 10-year retrospective study.
    Clin Rheumatol. 2025;44:1225-1236.
    >> Share

  292. VIEGAS-COSTA LC, Friesen R, Lai H, McGaw T, et al
    Serology and histology in Sjogren's syndrome diagnosis: a retrospective accuracy study.
    Clin Rheumatol. 2025;44:1197-1207.
    >> Share

    February 2025
  293. LI Y, Zhong S, Huang S, Zhong W, et al
    Application of metabolomics in the classification of traditional Chinese medicine syndromes in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 26. doi: 10.1007/s10067-025-07373.
    >> Share

  294. TASAMMA AT, Eshetu BZ, Seyoum AT, Woldegiorgis SA, et al
    Differences in rates of remission between rheumatoid factor positive and negative rheumatoid arthritis patients: experience from a resource-limited setting.
    Clin Rheumatol. 2025 Feb 25. doi: 10.1007/s10067-025-07370.
    >> Share

  295. VISWANATHAN A, Brahma N, Vimal S
    The future of autoimmune disease care: merging genomic insights and imaging for enhanced prognosis in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 22. doi: 10.1007/s10067-024-07234.
    >> Share

  296. SAIDI AN, Theel WB, Burggraaf B, van der Lelij AJ, et al
    Metabolic dysfunction-associated steatotic liver disease and cardiovascular risk factors in rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 17. doi: 10.1007/s10067-025-07364.
    >> Share

  297. WU H, Yin F, Wang Y, Tang Z, et al
    Increased macrophage migration inhibitory factor is associated with inflammation in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 14. doi: 10.1007/s10067-025-07361.
    >> Share

  298. MIKAEILI B, Alqahtani ZA, Hincapie AL, Guo JJ, et al
    Safety of Janus kinase inhibitors in rheumatoid arthritis: a disproportionality analysis using FAERS database from 2012 to 2022.
    Clin Rheumatol. 2025 Feb 13. doi: 10.1007/s10067-025-07360.
    >> Share

  299. MUSAEVA LM, Shestakova KM, Baskhanova SN, Varzieva VG, et al
    Evaluating treatment responsiveness in rheumatoid arthritis through predictive metabolomic profiling: A systematic review of studies examining methotrexate, TNF, and IL-6 inhibitors as therapeutic interventions.
    Clin Rheumatol. 2025 Feb 10. doi: 10.1007/s10067-025-07355.
    >> Share

  300. NANKI T, Yamaguchi T, Umetsu K, Tanabe R, et al
    Development and validation of a prediction model for serious infections in rheumatoid arthritis patients treated with tocilizumab in Japan.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07328.
    >> Share

  301. WANG H, Chu J, Wang Y, Wu Y, et al
    Mediating effect of X-26109 on the causal relationship between CD14(+) CD16(-) monocyte activation complex and rheumatoid arthritis in Europe.
    Clin Rheumatol. 2025 Feb 7. doi: 10.1007/s10067-025-07300.
    >> Share

  302. HAMMAM N, El-Hadidi T, El-Hadidi K, Elsaman A, et al
    International overview on juvenile-, adult- and elderly-onset rheumatoid arthritis: The age at disease onset as a fundamental determinant of clinical presentation.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07356.
    >> Share

  303. QWABE N, Paruk F, Mody GM
    Low prevalence of methotrexate intolerance in rheumatoid arthritis: a South African study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07310.
    >> Share

  304. XIE X, Wei G, Tang Z, Chen H, et al
    Investigating the causal relationship between rheumatoid arthritis and cardiovascular disease: A Mendelian randomization study.
    Clin Rheumatol. 2025 Feb 6. doi: 10.1007/s10067-025-07357.
    >> Share

  305. WU B, Dong Q, Zhang Q, Jin F, et al
    Protective effects of Catalpol to attenuate TNF- alpha and collagen-induced inflammation in vitro HFLS-RA cells and in vivo mice models for the treatment of rheumatoid arthritis.
    Clin Rheumatol. 2025 Feb 5. doi: 10.1007/s10067-024-07261.
    >> Share

  306. LONG D, Zhan J, Tu C, Yu S, et al
    Analysis of expression and its clinical significance of the ADAMTS-2 in systemic lupus erythematosus.
    Clin Rheumatol. 2025;44:681-691.
    >> Share

  307. LIAO Q, Zhao Y, Li X, Li X, et al
    Cerebral venous thrombosis as a rare complication of Sjogren's syndrome: case series and literature review.
    Clin Rheumatol. 2025;44:739-746.
    >> Share

    January 2025
  308. MOHAN A, Mohan A, Ramachandran A, Pulinilkunnathil JG, et al
    Anti-melanoma differentiation-associated gene 5 antibody-positive interstitial lung disease masquerading as rheumatoid arthritis-associated interstitial lung disease or overlapping with the same: a phenomenon driven by a probable genetic predispositio
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07351.
    >> Share

  309. UZUN GS, Sarikaya Y, Arslan S, Ekici M, et al
    ACPA is a main risk factor for CT-proven pulmonary nodule progression in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jan 30. doi: 10.1007/s10067-025-07344.
    >> Share

  310. PERNIOLA S, Bruno D, Di Mario C, Campobasso D, et al
    Residual pain and fatigue are affected by disease perception in rheumatoid arthritis in sustained clinical and ultrasound remission.
    Clin Rheumatol. 2025 Jan 22. doi: 10.1007/s10067-025-07331.
    >> Share

  311. HUANG Y, Li T, An Y, Lu D, et al
    Molecular mechanism of osteoclast differentiation of PBMC in patients with rheumatoid arthritis.
    Clin Rheumatol. 2025 Jan 18. doi: 10.1007/s10067-025-07322.
    >> Share

  312. XU B, Yu C
    Letter to editor "Health?related quality of life (HRQoL) loss associated with self?perceived anxiety/depression in seropositive rheumatoid arthritis".
    Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-024-07260.
    >> Share

  313. SENER S, Sener YZ
    Letter to the editor: Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findi
    Clin Rheumatol. 2025 Jan 17. doi: 10.1007/s10067-025-07330.
    >> Share

  314. WU S, Xie Y, Jiang Y, Zhang X, et al
    GTS-21 modulates rheumatoid arthritis Th17 and Th2 lymphocyte subset differentiation through the a7nAch receptor.
    Clin Rheumatol. 2025 Jan 15. doi: 10.1007/s10067-025-07320.
    >> Share

  315. HU X, Liu X, Xu Y, Zhang S, et al
    Machine learning-based prediction model integrating ultrasound scores and clinical features for the progression to rheumatoid arthritis in patients with undifferentiated arthritis.
    Clin Rheumatol. 2025 Jan 10. doi: 10.1007/s10067-025-07304.
    >> Share

  316. ALRIFAI N, Puttur A, Ghanem F, Dhital Y, et al
    Maternal and fetal outcomes in those with autoimmune connective tissue disease.
    Clin Rheumatol. 2025;44:391-401.
    >> Share

  317. KOPPEJAN H, Smith SI, Hameetman M, Toes REM, et al
    A small-scale preliminary study utilizing mass cytometry to distinguish two forms of arthritis.
    Clin Rheumatol. 2025;44:495-502.
    >> Share

  318. MANDOSI C, Matys V, Deroma M, Del Negro V, et al
    Ovarian reserve in patients with Sjogren's syndrome: a cross-sectional study.
    Clin Rheumatol. 2025;44:319-325.
    >> Share

  319. FAYET F, Beauvais C, Pereira B, Beranger M, et al
    Comparison of group versus individual patient education for promoting safety skills of patients with autoimmune rheumatic diseases treated with biologics: a multicentre randomised controlled trial.
    Clin Rheumatol. 2025;44:487-494.
    >> Share

  320. PANG R, Ma X, Guo H, Qi X, et al
    Meta-analysis of mortality-associated factors in primary Sjogren's syndrome patients with interstitial lung disease.
    Clin Rheumatol. 2025;44:23-31.
    >> Share

    December 2024
  321. TANG M, Du L, Peng J
    Urinary albumin-to-creatinine ratio for predicting risk of all-cause mortality and specific-cause mortality in patients with rheumatoid arthritis: evidence from NHANES 1999-2018.
    Clin Rheumatol. 2024 Dec 30. doi: 10.1007/s10067-024-07272.
    >> Share

  322. ZHOU W, Yang Y, Su L
    Development and validation of predictive factors influencing rheumatoid arthritis associated with interstitial lung disease.
    Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07282.
    >> Share

  323. HIJJAWI N, Tout FS, Azaizeh B, Aljaafreh B, et al
    The role of vitamins D, B12, C, and K in modulating inflammation and disease management in rheumatoid arthritis: a comprehensive review.
    Clin Rheumatol. 2024 Dec 26. doi: 10.1007/s10067-024-07285.
    >> Share

  324. WAN J, Cao X, Yang Y
    Decreased in-hospital mortality in shock patients with rheumatoid arthritis compared to those without: a retrospective analysis of a critical care database.
    Clin Rheumatol. 2024 Dec 24. doi: 10.1007/s10067-024-07280.
    >> Share

  325. HARROLD LR, Bingham CO, Pope JE, O'Brien J, et al
    Effectiveness of tofacitinib versus tumor necrosis factor inhibitors and in those receiving tofacitinib as different lines of therapy in patients with rheumatoid arthritis: results from the United States CorEvitas Rheumatoid Arthritis Registry.
    Clin Rheumatol. 2024 Dec 20. doi: 10.1007/s10067-024-07245.
    >> Share

  326. ZHAN W, Li R, Xu X
    The relationship between low-carbohydrate diet score, dietary macronutrient intake, and rheumatoid arthritis: results from NHANES 2011-2016.
    Clin Rheumatol. 2024 Dec 16. doi: 10.1007/s10067-024-07269.
    >> Share

  327. GUAJARDO-JAUREGUI N, Cardenas-de la Garza JA, Galarza-Delgado DA, Azpiri-Lopez JR, et al
    Inadequate identification of high cardiovascular risk and carotid plaques in rheumatoid arthritis patients by the 2024 Predicting Risk of Cardiovascular EVENTs and the 2013 Atherosclerotic Cardiovascular Disease algorithms: findings from a Mexican coh
    Clin Rheumatol. 2024 Dec 10. doi: 10.1007/s10067-024-07249.
    >> Share

  328. YANG L, Wang X, Gu B, Su D, et al
    Identifying the genetic association between rheumatoid arthritis and the risk of pulmonary arterial hypertension.
    Clin Rheumatol. 2024 Dec 6. doi: 10.1007/s10067-024-07258.
    >> Share

  329. FENG R, Xiao X, Wang Y, Huang B, et al
    Metabolic impact of low dose IL-2 therapy for primary Sjogren's Syndrome in a double-blind, randomized clinical trial.
    Clin Rheumatol. 2024;43:3789-3798.
    >> Share

  330. SHUAI XU, Dandan F, Liang XU
    Study on the changes and significance of CXCL10 level in serum of isolated polymyalgia rheumatica.
    Clin Rheumatol. 2024;43:3993-3998.
    >> Share

  331. TEIXEIRA RL, da Silva Vieira R, Saavedra MJ, Polido-Pereira J, et al
    Structured and prompt treatment of early arthritis in clinical practice leverages window of opportunity and leads to excellent clinical outcomes: an innovative retrospective cohort study.
    Clin Rheumatol. 2024;43:3941-3950.
    >> Share

  332. WANG X, Wu H, Zhong B, Zhang L, et al
    Autoantibody against aquaporin-5 may be a new diagnostic biomarker for primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:3781-3787.
    >> Share

  333. PENG LQ, Chen XH, Yang WJ, Huang WK, et al
    Can unstimulated whole salivary flow objectively classify salivary gland secretory function in Sjogren's syndrome?
    Clin Rheumatol. 2024;43:3771-3780.
    >> Share

    November 2024
  334. PANG X, Xu F, Fan C, Jiang H, et al
    Global research trends of MicroRNAs in rheumatoid arthritis: bibliometrics and visualization analysis.
    Clin Rheumatol. 2024 Nov 28. doi: 10.1007/s10067-024-07250.
    >> Share

  335. JIANG P, Shen Y, Chang C, Shi Y, et al
    HIPK3 hypomethylation as a potential epigenetic biomarker in rheumatic immune diseases with emphasis on rheumatoid arthritis.
    Clin Rheumatol. 2024 Nov 27. doi: 10.1007/s10067-024-07158.
    >> Share

  336. YAN L, Lin M, Ye X, Li W, et al
    Prediction model for bone erosion in rheumatoid arthritis based on musculoskeletal ultrasound and clinical risk factors.
    Clin Rheumatol. 2024 Nov 9. doi: 10.1007/s10067-024-07219.
    >> Share

  337. LYU Q, Ma L, Liu H, Shao H, et al
    Weight-adjusted waist index associated with bone mineral density in rheumatoid arthritis patients: a cross-sectional study.
    Clin Rheumatol. 2024 Nov 5. doi: 10.1007/s10067-024-07179.
    >> Share

  338. DAGHOR-ABBACI K, Laraba N, Dahou-Makhloufi C, Mechid F, et al
    Disease activity score for still's disease.
    Clin Rheumatol. 2024;43:3273-3283.
    >> Share

  339. CAI X, Jin J, Ye H, Xiang X, et al
    Altered serum metabolome is associated with disease activity and immune responses in rheumatoid arthritis.
    Clin Rheumatol. 2024 Nov 1. doi: 10.1007/s10067-024-07201.
    >> Share

    October 2024
  340. MAHMOUD EM, Radwan A, Elsayed SA
    A prospective randomized-controlled non-blinded comparative study of the JAK inhibitor (baricitinib) with TNF-alpha inhibitors and conventional DMARDs in a sample of Egyptian rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Oct 31. doi: 10.1007/s10067-024-07194.
    >> Share

  341. ROJAS-GUALDRON DF, Franco-Salazar C, Gomez-Henck CA, Manrique-Castrillon MC, et al
    Health-related quality of life (HRQoL) loss associated with self-perceived anxiety/depression in seropositive rheumatoid arthritis.
    Clin Rheumatol. 2024 Oct 30. doi: 10.1007/s10067-024-07186.
    >> Share

  342. D'ONOFRIO B, Selmi C, Gremese E
    Are seronegative patients with rheumatoid arthritis and clinically suspect arthralgia properly represented in randomized clinical trials?
    Clin Rheumatol. 2024 Oct 26. doi: 10.1007/s10067-024-07187.
    >> Share

  343. LI S, Chen Z, Yu H, Chang W, et al
    Association of magnesium deficiency scores with risk of rheumatoid arthritis and osteoarthritis in adults: a cross-sectional population-based study.
    Clin Rheumatol. 2024 Oct 25. doi: 10.1007/s10067-024-07203.
    >> Share

  344. TAHIR MW, Rosli Y, Leung C, Wysham KD, et al
    Frailty and its association with readmissions in patients with rheumatoid arthritis: A national readmissions database study.
    Clin Rheumatol. 2024 Oct 19. doi: 10.1007/s10067-024-07200.
    >> Share

  345. SHIH PC, Hung PC, Leong PY, Hsu JN, et al
    Incidence and risk factors of discontinuation of tofacitinib and biologic disease-modifying anti-rheumatic drugs among patients with rheumatoid arthritis: A population-based cohort study.
    Clin Rheumatol. 2024 Oct 11. doi: 10.1007/s10067-024-07161.
    >> Share

  346. ZHAO CN, Jiang LQ, Musonye HA, Meng SY, et al
    Associations of accelerated biological aging and metabolic heterogeneity of obesity with rheumatoid arthritis: a prospective cohort study.
    Clin Rheumatol. 2024 Oct 5. doi: 10.1007/s10067-024-07167.
    >> Share

  347. MOVAHEDI M, Cui K, Tomlinson G, Cesta A, et al
    Functional disability and disease activity are affected by social determinants of health in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Oct 4. doi: 10.1007/s10067-024-07148.
    >> Share

  348. LIN Q, Zhang C, Huang H, Bai Z, et al
    TLR2 reprograms glucose metabolism in CD4(+) T cells of rheumatoid arthritis patients to mediate cell hyperactivation and TNF-alpha secretion.
    Clin Rheumatol. 2024 Oct 2. doi: 10.1007/s10067-024-07125.
    >> Share

  349. XIA Z, Zong S, Zhou S, Rao Y, et al
    Rheumatoid arthritis and gliostatin: a two-sample Mendelian randomization analysis and RT-PCR validation.
    Clin Rheumatol. 2024 Oct 1. doi: 10.1007/s10067-024-07164.
    >> Share

  350. PHAN K, Chou S, Lee AYS
    Isolated cutaneous panniculitis in Sjogren's disease exacerbated by COVID-19 illness.
    Clin Rheumatol. 2024;43:3257-3258.
    >> Share

    September 2024
  351. SHI X
    Letter to the editor: "Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study".
    Clin Rheumatol. 2024 Sep 30. doi: 10.1007/s10067-024-07150.
    >> Share

  352. ANJIKI K, Hayashi S, Ikuta K, Suda Y, et al
    JAK inhibitors inhibit angiogenesis by reducing VEGF production from rheumatoid arthritis-derived fibroblast-like synoviocytes.
    Clin Rheumatol. 2024 Sep 20. doi: 10.1007/s10067-024-07142.
    >> Share

  353. ZHANG L, Shen Y
    Letter to the editor to "Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study".
    Clin Rheumatol. 2024 Sep 19. doi: 10.1007/s10067-024-07112.
    >> Share

  354. OU Y, Wu J, Zhu Y, Qi X, et al
    Application of superb microvascular imaging technology in clinical disease activity of rheumatoid arthritis.
    Clin Rheumatol. 2024 Sep 12. doi: 10.1007/s10067-024-07119.
    >> Share

  355. HAYASHI S, Nakano N, Tsubosaka M, Kamenaga T, et al
    Real-world study comparing the efficacy of Janus kinase inhibitors in patients with difficult-to-treat rheumatoid arthritis.
    Clin Rheumatol. 2024 Sep 7. doi: 10.1007/s10067-024-07117.
    >> Share

  356. SUAREZ-ALMAZOR ME, Ruiz JI, Lei X, Wu CF, et al
    Trends in the use of biologic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis and recently diagnosed colorectal, lung, or prostate cancer.
    Clin Rheumatol. 2024 Sep 4. doi: 10.1007/s10067-024-07135.
    >> Share

  357. ZAYENI H, Sojoudi S, Ghanbari AM, Masooleh IS, et al
    The effect of radiation synovectomy with phosphorus-32 on the pain and swelling in 31 RA patients with resistant monoarthritis of the knee.
    Clin Rheumatol. 2024;43:2791-2798.
    >> Share

    August 2024
  358. WANG X, Bai Y, Zou X, He X, et al
    Exploring the role of Life Essential 8 in patients diagnosed with systemic lupus erythematosus and rheumatoid arthritis.
    Clin Rheumatol. 2024 Aug 21. doi: 10.1007/s10067-024-07114.
    >> Share

  359. MALANI K, Pradhan S, Roberts M, Saquib N, et al
    Joint effect of rheumatoid arthritis and diet quality on cardiovascular and mortality outcomes: insights from the Women's Health Initiative.
    Clin Rheumatol. 2024 Aug 4. doi: 10.1007/s10067-024-07092.
    >> Share

  360. WANG X, Yang J, Yu LY, Zhang J, et al
    Effect of disease duration on the use of tofacitinib: a real-world study in elderly patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07084.
    >> Share

  361. CHEN DY
    Reply to "Letter to the Editor": Exploring Multidimensional Factors of Herpes Zoster Risk in Rheumatoid Arthritis Patients Undergoing JAK Inhibitor Treatment.
    Clin Rheumatol. 2024 Aug 2. doi: 10.1007/s10067-024-07087.
    >> Share

  362. JERIES H, Daood R, Naffaa ME
    Is interleukin-1 blockade a therapeutic option for patients with palindromic rheumatism?
    Clin Rheumatol. 2024;43:2715-2717.
    >> Share

  363. ZHU H, Wang Y, Wang G, Ling Y, et al
    The circular RNA hsa_circ_0045800 serves as a favorable biomarker in pathogenesis of sjogren's syndrome.
    Clin Rheumatol. 2024;43:2585-2594.
    >> Share

    July 2024
  364. PARK E, Iqbal R, Giles JT, Bernstein EJ, et al
    Use of methotrexate and TNF inhibitors in patients with rheumatoid arthritis-associated interstitial lung disease: a survey of rheumatologists.
    Clin Rheumatol. 2024 Jul 31. doi: 10.1007/s10067-024-07068.
    >> Share

  365. GU H, Yan D, Li J, Long X, et al
    Trends and future projections of incidence rate and mortality of rheumatoid arthritis in China: a systematic analysis based on GBD 2021 data.
    Clin Rheumatol. 2024 Jul 29. doi: 10.1007/s10067-024-07083.
    >> Share

  366. TONG B, Cheng W
    Letter to editor 'Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease'.
    Clin Rheumatol. 2024 Jul 22. doi: 10.1007/s10067-024-07075.
    >> Share

  367. ZHOU L, Xing Y, Li W
    Exploring multidimensional factors of herpes zoster risk in rheumatoid arthritis patients undergoing JAK inhibitor treatment.
    Clin Rheumatol. 2024 Jul 20. doi: 10.1007/s10067-024-07076.
    >> Share

  368. NOVELLA-NAVARRO M, Ruiz-Esquide V, Lopez-Juanes N, Chacur CA, et al
    Subsequent biologic and targeted synthetic disease modifying anti rheumatic drugs after fulfilling difficult-to-treat rheumatoid arthritis criteria: a survival analysis.
    Clin Rheumatol. 2024 Jul 16. doi: 10.1007/s10067-024-07070.
    >> Share

  369. CHEN PK, Chang SH, Chen YM, Chen HH, et al
    Prior herpes zoster occurrence and high-dose corticosteroids increase herpes zoster risk in rheumatoid arthritis patients receiving janus kinase inhibitors in a retrospective and observational study.
    Clin Rheumatol. 2024 Jul 2. doi: 10.1007/s10067-024-07041.
    >> Share

  370. FAYET F, Darmant N, Lambert C, Pereira B, et al
    Effect of Argentine tango sessions on total physical activity time in patients with chronic inflammatory rheumatism: randomized, controlled, pilot study.
    Clin Rheumatol. 2024;43:2215-2221.
    >> Share

  371. SOLTANI F, Khalaji A, Farzaneh R, Malek Mahdavi A, et al
    Performance of existing diagnostic criteria for palindromic rheumatism.
    Clin Rheumatol. 2024;43:2337-2342.
    >> Share

  372. ANSARI N, Salesi M
    The association between primary Sjogren's syndrome and non-Hodgkin's lymphoma: a systematic review and meta-analysis of cohort studies.
    Clin Rheumatol. 2024;43:2177-2186.
    >> Share

    June 2024
  373. WANG W, Xu Y, Zhou J, Zang Y, et al
    Effects of omega-3 supplementation on lipid metabolism, inflammation, and disease activity in rheumatoid arthritis: a meta-analysis of randomized controlled trials.
    Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07040.
    >> Share

  374. JANAHIRAMAN S, Shahril NS, Jayaraj VJ, Ch'ng S, et al
    A hierarchical cluster analysis for clinical profiling of tofacitinib treatment response in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 26. doi: 10.1007/s10067-024-07035.
    >> Share

  375. LIU F, Liu F, Wang H
    Association between Life's Essential 8 and rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 24. doi: 10.1007/s10067-024-07036.
    >> Share

  376. VENKAT RK, Hayashi K, Juge PA, McDermott G, et al
    Forced vital capacity trajectories and risk of lung transplant and ILD-related mortality among patients with rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2024 Jun 19. doi: 10.1007/s10067-024-07028.
    >> Share

  377. GADEHOLT O, Arnold E, Gorman C, Mueller T, et al
    Body mass index stratification enables cytokine-based prediction of ACPA status and Power-Doppler disease activity in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 14. doi: 10.1007/s10067-024-07032.
    >> Share

  378. HARRIS JT, Yang Y, Bentley JP, Chen Y, et al
    Estimation of optimal adherence threshold for tumor necrosis factor inhibitors in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jun 10. doi: 10.1007/s10067-024-06971.
    >> Share

  379. OPDAM MAA, Broeder ND, van den Bemt BJF, Mulder K, et al
    Higher infection risk for JAK inhibitors tofacitinib and baricitinib compared to subcutaneous biological DMARDs.
    Clin Rheumatol. 2024;43:2133-2138.
    >> Share

  380. SARIYILDIZ A, Coskun Benlidayi I, Yetisir A, Turk I, et al
    Central sensitization significantly deteriorates functionality and the interpretation of self-reported disease activity in primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1949-1958.
    >> Share

  381. GOLOVINA OA, Torgashina AV, Gorodetskiy VR, Sockol EV, et al
    Combination of Sjogren's syndrome and anti-Ku syndrome complicated by the development of mucosa-associated lymphoid tissue lymphoma: case review and systematic review of the literature.
    Clin Rheumatol. 2024;43:2145-2152.
    >> Share

  382. LIU H, Yuan J, Tan X, Song W, et al
    Male patients with primary Sjogren's syndrome have unique clinical manifestations and circulating lymphocyte profiles.
    Clin Rheumatol. 2024;43:1927-1937.
    >> Share

  383. XIE Y, Fan Y, Su M, Wang Y, et al
    Characteristics of the oral microbiota in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1939-1947.
    >> Share

  384. EL MIEDANY Y, El Gaafary M, Youssef S, El Aroussy N, et al
    Meaningful patient engagement in inflammatory arthritis: development of the Patient Motivation Questionnaire.
    Clin Rheumatol. 2024;43:1793-1801.
    >> Share

    May 2024
  385. CHEN G, Chen H, Wang Z, Cai H, et al
    Letter to the editor: "Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis".
    Clin Rheumatol. 2024 May 18. doi: 10.1007/s10067-024-07006.
    >> Share

  386. ABDULSALAM AJ, Analay P, Kara M
    Sarcopenia in rheumatoid arthritis: choose your weapons wisely.
    Clin Rheumatol. 2024 May 13. doi: 10.1007/s10067-024-07002.
    >> Share

  387. MURPHY L, Saab MM, Cornally N, McHugh S, et al
    Cardiovascular disease risk assessment in patients with rheumatoid arthritis: A scoping review.
    Clin Rheumatol. 2024 May 11. doi: 10.1007/s10067-024-06996.
    >> Share

  388. WAN J, Yu Z, Cao X, Zhao X, et al
    Multidimensional biomarker approach integrating tumor markers, inflammatory indicators, and disease activity indicators may improve prediction of rheumatoid arthritis-associated interstitial lung disease.
    Clin Rheumatol. 2024 May 5. doi: 10.1007/s10067-024-06984.
    >> Share

  389. HU W, Ding Y, Guan K, Zhang P, et al
    Changes in metabolic parameters and serum YKL-40 levels in Chinese rheumatoid arthritis patients during tocilizumab therapy.
    Clin Rheumatol. 2024 May 2. doi: 10.1007/s10067-024-06982.
    >> Share

  390. XU N, Wang X, Dai T, Liu N, et al
    Non-invasive imaging for predicting labial salivary gland biopsy outcomes in patients with suspected primary Sjogren syndrome.
    Clin Rheumatol. 2024;43:1683-1692.
    >> Share

  391. LU L, Dai T, Zhao Y, Qu H, et al
    The value of MRI-based radiomics for evaluating early parotid gland injury in primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1675-1682.
    >> Share

  392. CAI B, Guo Z, Yan Q, Li H, et al
    Clinical features and risk factors of primary Sjogren's syndrome complicated with severe pneumonia: a case-control study.
    Clin Rheumatol. 2024;43:1665-1674.
    >> Share

  393. AN Q, Ma R, Yuan D, Huang J, et al
    Clinical observation of hypofibrinogenemia induced by the treatment of tocilizumab in rheumatic diseases and exploration of risk factor for hypofibrinogenemia.
    Clin Rheumatol. 2024;43:1491-1501.
    >> Share

  394. LI H, Jin Y, He J
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:1777.
    >> Share

    April 2024
  395. SEPRIANO A, Ramiro S, Landewe R, van der Heijde D, et al
    Adding ultrasound to treat-to-target shows no benefit in achieving clinical remission nor in slowing radiographic progression in rheumatoid arthritis: results from a multicenter prospective cohort.
    Clin Rheumatol. 2024 Apr 29. doi: 10.1007/s10067-024-06978.
    >> Share

  396. LOZADA-MELLADO M, Llorente L, Hinojosa-Azaola A, Ogata-Medel M, et al
    Inflammatory profile in patients with rheumatoid arthritis and sarcopenia.
    Clin Rheumatol. 2024 Apr 26. doi: 10.1007/s10067-024-06974.
    >> Share

  397. SHEAHAN A, Anjohrin S, Suruki R, Stark JL, et al
    Opioid use surrounding diagnosis and follow-up in patients with ankylosing spondylitis, psoriatic arthritis, and rheumatoid arthritis: Results from US claims databases.
    Clin Rheumatol. 2024 Apr 25. doi: 10.1007/s10067-024-06945.
    >> Share

  398. LITTLEJOHN G, Anbumurali N, O'Sullivan C, Smith T, et al
    Optimising patient outcomes: temporal trends in remission rates of rheumatoid arthritis patients in the Australian OPAL dataset between 2009 and 2022.
    Clin Rheumatol. 2024 Apr 18. doi: 10.1007/s10067-024-06967.
    >> Share

  399. YETISIR A, Sariyildiz A, Turk I, Coskun Benlidayi I, et al
    Evaluation of inflammatory biomarkers and the ratio of hemoglobin-red cell distribution width in patients with rheumatoid arthritis treated with tumor necrosis factor-alpha inhibitors.
    Clin Rheumatol. 2024 Apr 15. doi: 10.1007/s10067-024-06963.
    >> Share

  400. ZHOU J, Gan Y, Fan X, Qi H, et al
    Latent class analysis of psychological resilience and influencing factors in patients with rheumatoid arthritis: a cross-sectional survey.
    Clin Rheumatol. 2024 Apr 10. doi: 10.1007/s10067-024-06959.
    >> Share

  401. YU T, Qian S, Li M
    Letter to the Editor: "Development and validation of equations for conversion from DAS28ESR and DAS28CRP to the SDAI in patients with rheumatoid arthritis".
    Clin Rheumatol. 2024 Apr 6. doi: 10.1007/s10067-024-06924.
    >> Share

  402. OLIVEIRA D, Ferreira RM, Gomes CM, Vaz C, et al
    Geiser Sign in a patient with rheumatoid arthritis.
    Clin Rheumatol. 2024 Apr 4. doi: 10.1007/s10067-024-06952.
    >> Share

  403. XIE Y, Zhao H
    Real respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1353.
    >> Share

  404. DAI W, He H
    Commentary on the respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease.
    Clin Rheumatol. 2024;43:1419-1420.
    >> Share

  405. LIU X, Wang H, Wang X, Jiang X, et al
    Identification and verification of inflammatory biomarkers for primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:1335-1352.
    >> Share

    March 2024
  406. BIRD A, Oakden-Rayner L, Smith LA, Zeng M, et al
    Prognostic modeling in early rheumatoid arthritis: reconsidering the predictive role of disease activity scores.
    Clin Rheumatol. 2024 Mar 27. doi: 10.1007/s10067-024-06946.
    >> Share

  407. GUPTA N, Kanwar N, Arora A, Khatri K, et al
    The interplay of rheumatoid arthritis and osteoporosis: exploring the pathogenesis and pharmacological approaches.
    Clin Rheumatol. 2024 Mar 18. doi: 10.1007/s10067-024-06932.
    >> Share

  408. LU F, Chen Q, Qi X, Cong M, et al
    Revealing the changes in signaling pathways caused by tofacitinib in patients with rheumatoid arthritis through RNA sequencing and the correlation with clinical parameters.
    Clin Rheumatol. 2024 Mar 16. doi: 10.1007/s10067-024-06931.
    >> Share

  409. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Correction to: Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Mar 15. doi: 10.1007/s10067-024-06907.
    >> Share

  410. ATHANASSIOU P, Katsimbri P, Bounas A, Gazi S, et al
    Persistence on subcutaneous tocilizumab as monotherapy or in combination with synthetic disease-modifying anti-rheumatic drugs in rheumatoid arthritis patients in Greece (EMBRACE study): a multicenter, post-marketing, non-interventional, observational
    Clin Rheumatol. 2024 Mar 12. doi: 10.1007/s10067-024-06916.
    >> Share

  411. OZ N, Gezer HH, Cilli Hayiroglu S, Duruoz MT, et al
    Evaluation of the prognostic nutritional index (PNI) as a tool for assessing disease activity in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Mar 11. doi: 10.1007/s10067-024-06927.
    >> Share

  412. PAN J, Wu T, Ma JD, Jia PW, et al
    Geriatric nutrition risk index: a more powerful index identifying muscle mass loss in patients with rheumatoid arthritis.
    Clin Rheumatol. 2024 Mar 4. doi: 10.1007/s10067-024-06918.
    >> Share

  413. SUZUKI S, Kataoka Y, Otani T, Taniguchi Y, et al
    Optimal time of starting tocilizumab in acute phase of adult-onset Still's disease and comparison of its efficacy with that of methotrexate: a case series and a review of the literature.
    Clin Rheumatol. 2024;43:1245-1251.
    >> Share

  414. BOHMAN BR, Dowds HS, Blagogee TE, Ike RW, et al
    Sjogren's disease activity associates with cardiovascular disease and monoclonal gammopathy: a university cohort study of disease activity and comorbidities.
    Clin Rheumatol. 2024;43:1093-1101.
    >> Share

  415. BAO X
    Validation of new immune and inflammation-related diagnostic biomarkers for RA.
    Clin Rheumatol. 2024;43:949-958.
    >> Share

  416. ESPINOSA-BAUTISTA F, Salazar-Sanchez MI, Brianza-Padilla M, Leon-Avila G, et al
    Dysregulation of long non-coding RNAs in Takayasu arteritis: A proof-of-concept study.
    Clin Rheumatol. 2024;43:1253-1259.
    >> Share

  417. PHAM C, Niu F, Hui RL, Le KN, et al
    Patient perceptions on switching from reference product adalimumab to biosimilar adalimumab-atto.
    Clin Rheumatol. 2024;43:1269-1270.
    >> Share

    February 2024
  418. CHEN D, Zhang J
    Commentary on the factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2024 Feb 23. doi: 10.1007/s10067-024-06896.
    >> Share

  419. WANG B, Liu J, Zhao L
    Association of congestive heart failure with mortality in individuals with rheumatoid arthritis: a cohort study.
    Clin Rheumatol. 2024 Feb 20. doi: 10.1007/s10067-024-06878.
    >> Share

  420. FERNANDEZ-AVILA DG, Patino-Hernandez D, Moreno-Luna S, Brance L, et al
    Development of a novel clinimetric tool: PAtient Reported Disease Activity Index in Rheumatoid Arthritis (PARDAI-RA) by PANLAR, for the assessment of patients living with rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 14. doi: 10.1007/s10067-024-06868.
    >> Share

  421. LICHTIGER A, Fadaei G, Tagoe CE
    Autoimmune thyroid disease and rheumatoid arthritis: where the twain meet.
    Clin Rheumatol. 2024 Feb 10. doi: 10.1007/s10067-024-06888.
    >> Share

  422. NOMAIR AM, Abdelati A, Dwedar FI, Elnemr R, et al
    The impact of folate pathway variants on the outcome of methotrexate therapy in rheumatoid arthritis patients.
    Clin Rheumatol. 2024 Feb 5. doi: 10.1007/s10067-024-06892.
    >> Share

  423. ZHANG L, Tan M, Mao J, Zhang J, et al
    Natural compound library screening to identify berberine as a treatment for rheumatoid arthritis.
    Clin Rheumatol. 2024 Feb 2. doi: 10.1007/s10067-024-06871.
    >> Share

  424. LERCARA A, Malattia C, Hysa E, Gattorno M, et al
    Microvascular status in juvenile Sjogren's disease: the first nailfold videocapillaroscopy investigation.
    Clin Rheumatol. 2024;43:733-741.
    >> Share

  425. ZHAO R, Dong C, Gu Z, Ding X, et al
    Development and validation of a nomogram for predicting fatigue in patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:717-724.
    >> Share

  426. ZHOU X, Li H, Wang N, Jin Y, et al
    Respiratory infection risk in primary Sjogren's syndrome complicated with interstitial lung disease: a retrospective study.
    Clin Rheumatol. 2024;43:707-715.
    >> Share

  427. SHEN Y, Yu X, Wang Q, Yao X, et al
    Association between primary Sjogren's syndrome and gut microbiota disruption: a systematic review and meta-analysis.
    Clin Rheumatol. 2024;43:603-619.
    >> Share

    January 2024
  428. O'BRIEN J, Park SH, Blachley T, Marchese M, et al
    Disparities in burden of disease in patients with rheumatoid arthritis across racial and ethnic groups.
    Clin Rheumatol. 2024 Jan 25. doi: 10.1007/s10067-024-06869.
    >> Share

  429. QIAO L, Lv S, Meng K, Yang J, et al
    Genetically proxied therapeutic inhibition of lipid-lowering drug targets and risk of rheumatoid arthritis disease: a Mendelian randomization study.
    Clin Rheumatol. 2024 Jan 10. doi: 10.1007/s10067-023-06837.
    >> Share

  430. HARADA H, Kondo M, Maeyama A, Fukuda T, et al
    Effectiveness and safety of sarilumab in patients with rheumatoid arthritis: A multicenter, retrospective, inverse probability of treatment-weighted analysis based on the FRAB-registry.
    Clin Rheumatol. 2024 Jan 6. doi: 10.1007/s10067-023-06862.
    >> Share

  431. SHIZUKU T, Hagino N
    Hypoglossal nerve palsy due to basilar impression in rheumatoid arthritis.
    Clin Rheumatol. 2024 Jan 3. doi: 10.1007/s10067-023-06863.
    >> Share

  432. YIN S, Luo F, Xie J, Zeng Y, et al
    Identification of discriminatory factors and construction of nomograms for differentiating AOSD and sepsis.
    Clin Rheumatol. 2024;43:569-578.
    >> Share

  433. RUAN Y, Bi H, Luo X, Pang A, et al
    Elevated plasma levels of specific antiplatelet glycoprotein autoantibodies in patients with primary Sjogren syndrome with thrombocytopenia.
    Clin Rheumatol. 2024;43:307-314.
    >> Share

  434. SAMI F, Sami SA, Manadan AM, Arora S, et al
    Nationwide analysis of neuromyelitis optica in systemic lupus erythematosus and Sjogren's syndrome.
    Clin Rheumatol. 2024;43:59-65.
    >> Share

  435. FARES J, Summer R, Loizidis G
    Low utilization of statins in patients with dermatomyositis/polymyositis and hyperlipidemia: a multicenter USA-based study (2013-2023).
    Clin Rheumatol. 2024;43:325-338.
    >> Share

  436. CHEN L, Chi H, Teng J, Meng J, et al
    Neutralizing anti-IFN-gamma IgG was increased in patients with systemic lupus erythematosus and associated with susceptibility to infection.
    Clin Rheumatol. 2024;43:189-198.
    >> Share

  437. ZHAO P, Peng C, Chang X, Cheng W, et al
    Decreased expression of TIGIT on CD14 + monocytes correlates with clinical features and laboratory parameters of patients with primary Sjogren's syndrome.
    Clin Rheumatol. 2024;43:297-306.
    >> Share

  438. KIADALIRI A, Dell'Isola A, Englund M
    Inflammatory rheumatic diseases and the risk of drug use disorders: a register-based cohort study in Sweden.
    Clin Rheumatol. 2024;43:81-85.
    >> Share

  439. CAI D, Zheng Z, Hu J, Fu Y, et al
    Immune-mediated inflammatory diseases and the risk of valvular heart disease: a Mendelian randomization study.
    Clin Rheumatol. 2024;43:533-541.
    >> Share

    December 2023
  440. SLOUMA M, Lahmar W, Mohamed G, Dhrif O, et al
    Associated factors with liver fibrosis in rheumatoid arthritis patients treated with methotrexate.
    Clin Rheumatol. 2023 Dec 30. doi: 10.1007/s10067-023-06847.
    >> Share

  441. WEMAN L, Salo H, Kuusalo L, Huhtakangas J, et al
    Similar levels of disease activity and remission rates in patients with psoriatic arthritis and rheumatoid arthritis-results from the Finnish quality register.
    Clin Rheumatol. 2023 Dec 28. doi: 10.1007/s10067-023-06850.
    >> Share

  442. OZUDOGRU CELIK T
    Letter to the Editor on "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06823.
    >> Share

  443. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    Rebuttal Letter to "The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients".
    Clin Rheumatol. 2023 Dec 27. doi: 10.1007/s10067-023-06856.
    >> Share

  444. D'ALESSANDRO F, Cazzato M, Laurino E, Morganti R, et al
    ToRaRI (Tofacitinib in Rheumatoid Arthritis a Real-Life experience in Italy): Effectiveness, safety profile of tofacitinib and concordance between patient-reported outcomes and physician's global assessment of disease activity in a retrospective study
    Clin Rheumatol. 2023 Dec 23. doi: 10.1007/s10067-023-06836.
    >> Share

  445. LIU H, Zhang Y, Cao J, Li J, et al
    Sema4D as a biomarker for Predicting rheumatoid arthritis disease activity.
    Clin Rheumatol. 2023 Dec 14. doi: 10.1007/s10067-023-06840.
    >> Share

  446. MO H, Su ZH, Zheng ZY, Gao L, et al
    Screening for early rheumatoid arthritis using high-frequency ultrasound, serum RANKL, and OPG detection.
    Clin Rheumatol. 2023 Dec 5. doi: 10.1007/s10067-023-06830.
    >> Share

  447. KARAMALI N, Mahmoudi Z, Roghani SA, Assar S, et al
    Overexpression of Synoviolin and miR-125a-5p, miR-19b-3p in peripheral blood of rheumatoid arthritis patients after treatment with conventional DMARDs and methylprednisolone.
    Clin Rheumatol. 2023 Dec 4. doi: 10.1007/s10067-023-06808.
    >> Share

  448. HE J, Xu C, Zhu Y, Xu M, et al
    Clinical significance of the expression levels of serum transforming growth factor-beta and CXC type chemokine ligand 13 in primary Sjogren's syndrome patients.
    Clin Rheumatol. 2023;42:3283-3288.
    >> Share

  449. SCHMIDT NS, Fana V, Danielsen MA, Lindegaard HM, et al
    The impact of an ultrasound atlas for scoring salivary glands in primary Sjogren's syndrome: a pilot study.
    Clin Rheumatol. 2023;42:3275-3281.
    >> Share

  450. YIN H, Yang S, Lu L
    Adie's tonic pupil in primary Sjogren syndrome.
    Clin Rheumatol. 2023;42:3419-3420.
    >> Share

    November 2023
  451. SHAMSI A, Roghani SA, Soufivand P, Pournazari M, et al
    CXCL9 and NT-proBNP, a notable link between inflammatory mediator and cardiovascular disease biomarker in rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 25. doi: 10.1007/s10067-023-06826.
    >> Share

  452. PALMOWSKI A, Strehl C, Pfeiffenberger M, Haupl T, et al
    Identification of gene expression biomarkers to predict clinical response to methotrexate in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Nov 17. doi: 10.1007/s10067-023-06814.
    >> Share

  453. RONG JC, Chen XD, Jin NK, Hong J, et al
    Exploring the causal association of rheumatoid arthritis with atrial fibrillation: a Mendelian randomization study.
    Clin Rheumatol. 2023 Nov 6. doi: 10.1007/s10067-023-06804.
    >> Share

  454. HUANG Y, Qiu Y, Xie Z, Zhang F, et al
    Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case?control study.
    Clin Rheumatol. 2023;42:3033-3041.
    >> Share

  455. MASHAYEKHI M, Khalaji A, Malek Mahdavi A, Khabbazi A, et al
    Outcomes of undifferentiated peripheral inflammatory arthritis in real-world practice. A longitudinal cohort study.
    Clin Rheumatol. 2023;42:3143-3152.
    >> Share

  456. SANTOS CS, Salgueiro RR, Morales CM, Castro CA, et al
    Risk factors for cardiovascular disease in primary Sjogren's syndrome (pSS): a 20-year follow-up study.
    Clin Rheumatol. 2023;42:3021-3031.
    >> Share

  457. WISE L, Zell M
    Adult-onset Still's disease complicated by macrophage activation syndrome during pregnancy: a case-based review.
    Clin Rheumatol. 2023;42:3159-3166.
    >> Share

    October 2023
  458. ADELOWO O, Omokhowa A, Ochiagha O, Uhunmwangho CU, et al
    Comorbidities in Nigerian patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 23. doi: 10.1007/s10067-023-06797.
    >> Share

  459. VALLEZ-VALERO L, Gaso-Gago I, Marcos-Fendian A, Garrido-Alejos G, et al
    Are all JAK inhibitors for the treatment of rheumatoid arthritis equivalent? An adjusted indirect comparison of the efficacy of tofacitinib, baricitinib, upadacitinib, and filgotinib.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06787.
    >> Share

  460. LI WJ, Wang XL, Chu YR, Wang JX, et al
    Association of sarcopenia and vitamin D deficiency with glucocorticoid-induced osteoporosis in Chinese patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 13. doi: 10.1007/s10067-023-06784.
    >> Share

  461. YAGIZ B, Coskun BN, Halil EY, Dalkilic E, et al
    The efficacy and reliability of English YouTube videos as a source of information for pregnant rheumatoid arthritis patients.
    Clin Rheumatol. 2023 Oct 9. doi: 10.1007/s10067-023-06780.
    >> Share

  462. PAN S, Xiao X, Li T, Wu S, et al
    Definition of follicular helper T cell and cytokines expression in synovial fluid of rheumatoid arthritis.
    Clin Rheumatol. 2023 Oct 4. doi: 10.1007/s10067-023-06772.
    >> Share

  463. TESCH F, Ehm F, Vivirito A, Wende D, et al
    Incident autoimmune diseases in association with SARS-CoV-2 infection: a matched cohort study.
    Clin Rheumatol. 2023;42:2905-2914.
    >> Share

  464. ZIMBA O, Gasparyan AY
    Cardiovascular issues in rheumatic diseases.
    Clin Rheumatol. 2023;42:2535-2539.
    >> Share

  465. GALARZA-DELGADO DA, Azpiri-Lopez JR, Colunga-Pedraza IJ, Cardenas-de la Garza JA, et al
    Cardiovascular health worsening in patients with autoimmune rheumatological diseases during the COVID-19 pandemic.
    Clin Rheumatol. 2023;42:2677-2690.
    >> Share

    September 2023
  466. WEINSTEIN CLJ, Meehan AG, Lin J, Briscoe SD, et al
    Long-term golimumab persistence: Five-year treatment retention data pooled from pivotal Phase III clinical trials in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis.
    Clin Rheumatol. 2023 Sep 26. doi: 10.1007/s10067-023-06760.
    >> Share

  467. LIU H, Li Q, Long K, Xia O, et al
    Rheumatoid arthritis with pulmonary accelerated rheumatoid nodules treated by baricitinib: a case-based review.
    Clin Rheumatol. 2023 Sep 23. doi: 10.1007/s10067-023-06773.
    >> Share

  468. NAKAYAMA M, Furuya T, Inoue E, Tanaka E, et al
    Factors associated with sarcopenia in Japanese patients with rheumatoid arthritis: results from the IORRA cohort study.
    Clin Rheumatol. 2023 Sep 21. doi: 10.1007/s10067-023-06779.
    >> Share

  469. RAZMJOU AA, Wang JM, Shahbazian A, Reddy S, et al
    Correction to: Suppressed paraoxonase-1 activity associates with elevated oxylipins and the presence of small airways disease in patients with rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 14. doi: 10.1007/s10067-023-06768.
    >> Share

  470. CHEN YW, Chen HH, Huang WN, Chen JP, et al
    Potential alleviation of bone mineral density loss with Janus kinase inhibitors in rheumatoid arthritis.
    Clin Rheumatol. 2023 Sep 2. doi: 10.1007/s10067-023-06735.
    >> Share

    November 2022
  471. CANSU DU, Korkmaz C
    Pulmonary hypertension in connective tissue diseases: epidemiology, pathogenesis, and treatment.
    Clin Rheumatol. 2022 Nov 17. pii: 10.1007/s10067-022-06446.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016